{
  "name": "EveryGene Study Resources",
  "url": "https://every-gene.academy/guides/",
  "items": [
    {
      "type": "guide",
      "title": "Compare Genetics Board Prep Resources",
      "url": "https://every-gene.academy/guides/choose-genetics-question-bank/",
      "description": "Compare EveryGene Academy, StudyRare, GC Test Prep, and CGCMaster by price, access, resets, and refund policy.",
      "author": "EveryGene",
      "updated": "2026-11-08",
      "text": "Full access. A learner-friendly price.\n\n### The complete genetics question bank, starting at $79.\n\nEvery question. Every feature. Unlimited resets.\n\nChoose 2, 3, or 18 months of practice. Every paid plan includes the same question bank and tools, with an unconditional seven-day refund.\n\nTry the Free Demo (https://app.every-gene.academy/demo) View Plans (https://every-gene.academy/pricing/)\n\n### See what your study budget includes\n\nReviewed November 7, 2026. Prices are in USD. StudyRare includes live teaching and recordings. “Not confirmed” means unverified, not unavailable. Prices and access terms can change; check the linked providers before purchasing.\n\nOn smaller screens, scroll the table sideways to compare all four providers.\n\nGenetics board prep: price, access, and practice features\n\nFeature | EveryGene AcademyEvery feature in every plan | StudyRare | GC Test Prep | CGCMaster |\n\nPaid access price | $79 / 2 months $109 / 3 months $199 / 18 months | $499 bootcamp; $399 with early-bird code through Dec. 1, 2026 | $100 Essential $150 Premium | Current price not confirmed |\n\nAll questions and features | Included in every paid plan | Included in bootcamp package | Reset and pass protection listed as Premium features | Plan differences not confirmed |\n\nAccess options | 2, 3, or 18 months | Current ABGC course through March 2, 2027 | Through Feb. 28, 2027; eligible pass protection can extend it | 18-month option not confirmed |\n\nQuestion-bank resets | Unlimited in every plan | Not confirmed | Once per test cycle; Premium | Not confirmed |\n\nRefund policy | Unconditional seven-day refund | Digital purchases final once access granted | Not confirmed | Not confirmed |\n\nPhysical study option | Original 101-condition flashcard deck (https://www.every-gene.com/genetics-flashcard-deck) ; sold separately | Print workbook; sold separately | Digital flashcards advertised | Physical deck not confirmed |\n\nSources: EveryGene pricing (https://every-gene.academy/pricing/) and refund terms (https://every-gene.academy/terms/) ; StudyRare bootcamp (https://studyrare.com/genetic-counselor-bootcamp) and books (https://studyrare.com/books) ; GC Test Prep (https://gctestprep.com/) and release notes (https://gctestprep.com/release-notes) ; CGCMaster’s company profile (https://www.linkedin.com/company/cgcmaster) . Published by EveryGene.\n\n### More room to practice, for less upfront\n\n#### Start at $79\n\nOur two-month plan costs $21 less upfront than GC Test Prep Essential’s listed $100 price. Access periods differ; choose the window that fits your study plan.\n\n#### Every feature from day one\n\nYour access duration determines your price. Detailed explanations, customizable tests, analytics, and unlimited resets are included in every paid plan.\n\n#### Time to return and review\n\nChoose 18 months for $199, paid once. Revisit the full bank throughout training and reset as often as you like.\n\n### Everything you need to practice, included in every plan.\n\n- Customize tests by topic, question count, and timing. Review missed, unused, or flagged questions.\n\n- Eliminate answer choices, flag questions, and navigate between them. Pause and resume sessions.\n\n- Track performance with analytics, review detailed explanations, and reset the entire bank as often as you like.\n\nPractice Shared Core Genetics, ABGC-focused, and ABMGG-focused content with one plan. Training programs can request group pricing (https://every-gene.academy/for-training-programs/) for 18-month access.\n\n### Built and led by practicing genetics clinicians and educators\n\nEveryGene Academy is developed, reviewed, and led by clinically practicing genetic counselors and medical geneticists working in academic medicine. We care for patients and teach future genetics professionals—bringing those perspectives directly into your board preparation.\n\nUsed by more than 400 learners, with learner feedback helping us improve the material over time.\n\nTry the Free Demo (https://app.every-gene.academy/demo) View Plans (https://every-gene.academy/pricing/)"
    },
    {
      "type": "article",
      "title": "Essential Genetics Terms for Board Exam Candidates",
      "url": "https://every-gene.academy/articles/genetics-glossary-key-terms/",
      "description": "Review genetics terms for ABGC and ABMGG board prep, from inheritance and variant interpretation to cytogenetics. Build vocabulary with examples and key notes.",
      "author": "EveryGene",
      "published": "2026-11-04",
      "updated": "2026-11-06",
      "text": "Precise vocabulary matters in genetics questions. Knowing that penetrance differs from expressivity, or understanding what haploinsufficiency means mechanistically, can change how you read a vignette. This glossary covers core terms for both genetic counseling and medical genetics preparation and flags common shortcuts that need qualification.\n\nDefinitions are introductory. For variant classification and clinical use, consult the current ACMG/AMP guidance (https://pubmed.ncbi.nlm.nih.gov/25741868/) , ClinGen PVS1 recommendations (https://pubmed.ncbi.nlm.nih.gov/30192042/) , and condition-specific GeneReviews (https://www.ncbi.nlm.nih.gov/books/NBK1116/) chapters.\n\n### Core Genetics Vocabulary\n\n#### Allele\n\nA version of a DNA sequence at a particular locus. For a typical autosomal locus in a diploid cell, a person inherits two alleles, one from each parent. Alleles can differ in sequence, copy number, or regulation.\n\nUse it precisely: dominance and recessiveness describe the relationship between alleles for a phenotype under a model; they are not complete intrinsic labels for every allele. A \"dominant\" allele is not universally dominant for every trait or in every context.\n\nWhy it matters: Many questions turn on whether a variant is present on one copy, both copies, or in trans with another variant.\n\n#### Locus\n\nA locus is a genomic position or region. It may correspond to a gene, but it can also be an intergenic position, a regulatory element, or a chromosomal band.\n\nUse it precisely: \"locus\" is not a synonym for \"gene.\" A probe or variant can target a locus without describing a whole gene.\n\n#### Penetrance\n\nThe proportion of individuals with a given genotype who show the associated phenotype, under defined conditions. If a condition is 80% penetrant, about 20% of people with the pathogenic variant would not show the phenotype in the population and time frame studied.\n\nUse it precisely: penetrance depends on the phenotype definition, age or time horizon, and population context. Penetrance estimates can inform risk counseling, but an individual's risk also depends on age, the phenotype being estimated, and other relevant factors. Penetrance is different from confidence in a variant's classification.\n\n#### Expressivity\n\nThe degree or range of severity of the phenotype among individuals who have the same genotype. Variable expressivity means the same variant can produce mild findings in one person and severe findings in another.\n\nWhy it matters: Distinguish whether a phenotype occurs (penetrance) from how it manifests (expressivity). Neurofibromatosis type 1 and Marfan syndrome are commonly used examples of variable expressivity.\n\n#### De Novo Variant\n\nA variant present in an individual but not detected in either parent's tested sample, arising in a gamete or early embryo. Common in some severe autosomal dominant conditions, including achondroplasia and Dravet syndrome.\n\nUse it precisely: a variant identified in a child and not detected in parental blood may still reflect parental germline mosaicism. Testing blood does not assess every parental tissue or gamete. An apparently de novo result should be interpreted with the laboratory's testing scope and the possibility of mosaicism in mind.\n\n#### Haploinsufficiency\n\nA mechanism in which one functional copy of a gene is insufficient for normal function, producing a phenotype. It is one form of loss-of-function disease mechanism.\n\nExample: PAX6-related aniridia (https://www.ncbi.nlm.nih.gov/books/NBK1360/) illustrates how loss of one functional copy can cause disease through haploinsufficiency.\n\nUse it precisely: loss of function and haploinsufficiency are related but not interchangeable terms. A variant can reduce function without producing disease through haploinsufficiency, and some loss-of-function variants act through other mechanisms.\n\n#### Imprinting (Genomic Imprinting)\n\nAn epigenetic phenomenon in which gene expression depends on the parent of origin. Imprinted genes are expressed from only the maternal or paternal copy, based on epigenetic marks such as DNA methylation.\n\nWhy it matters: Prader-Willi and Angelman syndromes both involve 15q11-q13 but have different phenotypes depending on the parent of origin. Beckwith-Wiedemann syndrome is another example of an imprinting disorder. A methylation result can establish an abnormal pattern without identifying whether the cause is a deletion, uniparental disomy, or an imprinting defect.\n\n#### Anticipation\n\nA phenomenon in which a disorder has earlier onset or greater severity in successive generations, usually described for specific repeat-expansion disorders.\n\nWhy it matters: Myotonic dystrophy type 1 (CTG repeat), Huntington disease (CAG repeat), and fragile X syndrome (CGG repeat) are commonly used examples. Anticipation is condition-specific; it is not a general feature of all inherited disorders.\n\n#### Germline and Somatic Variants\n\nA germline variant is present in germline cells and can be transmitted through a gamete. A variant confined to somatic tissues is not expected to be transmitted. An early postzygotic variant may involve both somatic and germline lineages.\n\nUse it precisely: germline variants are not restricted to reproductive organs, and not every early embryonic variant is confined to somatic tissue. Mosaicism is a separate concept that can involve either or both lineages.\n\nWhy it matters: In cancer genetics, a germline BRCA1 variant has implications for family risk, while a somatic TP53 variant confined to a tumor does not carry the same inheritance implications.\n\n#### Heteroplasmy\n\nThe presence of more than one type of mitochondrial DNA (mtDNA) within a cell or organism — typically variant and wild-type mtDNA. Heteroplasmy level and tissue distribution can influence phenotype.\n\nUse it precisely: higher levels of a pathogenic mtDNA variant do not provide a universal severity formula across people, tissues, variants, and disorders. Leigh syndrome can result from nuclear or mitochondrial gene variants; a syndrome name alone does not establish heteroplasmy or maternal inheritance.\n\n#### Variant of Uncertain Significance (VUS)\n\nA variant with insufficient evidence to classify it as pathogenic or benign under the applicable framework. The ACMG/AMP framework uses five categories: pathogenic, likely pathogenic, uncertain significance, likely benign, and benign.\n\nUse it precisely: a VUS may be reclassified, but resolution is not guaranteed. A VUS alone does not establish a diagnosis or justify variant-directed management. Care may still follow the person's clinical findings and family history, and additional evidence may support future reclassification.\n\nWhy it matters: VUS communication is a common counseling topic. The useful messages are uncertainty, what evidence would change the classification, and what the result does and does not mean for care.\n\n#### Pathogenic Variant\n\nA variant causally associated with disease based on sufficient evidence under a recognized classification framework. The field increasingly uses \"variant\" rather than \"mutation\" for sequence changes.\n\nUse it precisely: pathogenic, likely pathogenic, VUS, likely benign, and benign are classification categories. They are not the same as a patient's probability of disease, which also depends on penetrance, age, and context.\n\n#### Loss of Heterozygosity (LOH)\n\nLoss of heterozygosity describes a region where the two alleles are no longer both represented as expected. It can result from deletion, mitotic recombination, or other mechanisms, including copy-neutral LOH.\n\nUse it precisely: LOH does not always mean that a physical copy of an allele was deleted. In a tumor-suppressor model, LOH can provide a \"second hit,\" but not every second hit is a deletion. In BRCA1/2 carriers, the inherited pathogenic variant can be the first hit and LOH in a tumor cell the second.\n\n#### Frameshift Variant\n\nWithin a protein-coding sequence, an insertion or deletion whose net length is not a multiple of three can shift the reading frame. A noncoding indel does not automatically cause a frameshift, although it may affect splicing or regulation. This can produce a different amino acid sequence and often a premature stop codon.\n\nUse it precisely: a predicted frameshift is not automatically pathogenic. The ACMG/AMP PVS1 criterion applies in a gene where loss of function is an established disease mechanism, with transcript, exon, rescue, and other context considered. Evidence strength and final classification are separate decisions.\n\n#### Splicing Variant\n\nA DNA change that affects splicing signals or creates or alters a splice site, potentially causing exon skipping, intron retention, or use of a cryptic splice site. Effects can involve canonical splice sites or deeper intronic regions.\n\nUse it precisely: splice effects may require RNA-level or other functional evidence to classify.\n\n#### Copy Number Variant (CNV)\n\nA structural variant that changes the number of copies of a DNA segment. CNVs can affect gene dosage and contribute to disease through deletion, duplication, or disruption.\n\nUse it precisely: assay resolution and analysis determine what is detected. Not every CNV is pathogenic, and not every CNV is limited to a microarray finding.\n\nWhy it matters: Chromosomal microarray is a key test in developmental delay, autism, and congenital anomalies, but a normal dosage result does not exclude every mechanism.\n\n#### Single Nucleotide Variant (SNV) and Single Nucleotide Polymorphism (SNP)\n\nAn SNV is a single-nucleotide change in a DNA sequence. SNP is often used for a common single-nucleotide variation in a population, with terminology varying by context.\n\nUse it precisely: frequency informs interpretation but does not independently establish benignity or pathogenicity. Most SNPs are common population variation; some are associated with disease risk. \"SNP\" is not simply the benign counterpart of \"pathogenic variant.\"\n\nWhy it matters: SNVs underlie many genetic association studies and polygenic risk scores, but a variant's frequency and its clinical significance are different questions.\n\n#### Indel\n\nAn insertion or deletion of one or more nucleotides. Within a protein-coding sequence, an insertion or deletion whose net length is not a multiple of three can shift the reading frame. A noncoding indel does not automatically cause a frameshift, although it may affect splicing or regulation. Larger indels can overlap with copy-number changes.\n\nWhy it matters: Indels are commonly identified on sequencing panels and exome or genome sequencing. The classification still depends on gene context, predicted effect, and evidence.\n\n#### Aneuploidy\n\nAn abnormal chromosome number — an extra chromosome (for example, trisomy 21) or a missing chromosome (for example, monosomy X in Turner syndrome). Aneuploidy is a major cause of pregnancy loss and congenital anomalies.\n\nWhy it matters: Know the common trisomies (13, 18, 21), sex chromosome aneuploidies (45,X; 47,XXY; 47,XYY; 47,XXX), and their clinical associations, while recognizing that presentation varies.\n\n#### Balanced Reciprocal Translocation\n\nA rearrangement in which segments from two chromosomes exchange positions without a net gain or loss of genetic material at the resolution evaluated. Carriers are often phenotypically normal but can have an increased risk of unbalanced offspring.\n\nUse it precisely: \"balanced\" describes the copy-number result, not a guarantee of clinical neutrality. Apparently balanced rearrangements can disrupt genes or have other effects. See Robertsonian translocations (https://every-gene.academy/articles/genetics-glossary-key-terms/#robertsonian-translocation) for a different rearrangement mechanism.\n\n#### Robertsonian Translocation\n\nA translocation in which the long arms of two acrocentric chromosomes (13, 14, 15, 21, 22) fuse, with loss of the short arms. The carrier usually has 45 chromosomes and can have a normal phenotype.\n\nWhy it matters: rob(14;21) and rob(21;21) are important for Down syndrome recurrence counseling. The parent of origin and the specific translocation affect the risk.\n\n#### Mosaicism\n\nThe presence of two or more genetically distinct cell populations in an individual, derived from one fertilized egg. Mosaicism can be somatic, germline, or combined.\n\nUse it precisely: mosaicism does not guarantee a mild phenotype. A variant identified in a child and not detected in parental blood may still reflect parental germline mosaicism. Testing blood does not assess every parental tissue or gamete.\n\nWhy it matters: Germline mosaicism can explain parents with normal blood testing who have multiple affected children. Somatic mosaicism can explain variable or milder presentations of a condition.\n\n#### Proband\n\nThe person through whom a family first comes to clinical attention for a genetic concern. A proband may be affected or may be undergoing risk assessment.\n\nUse it precisely: \"index case\" and \"proband\" are sometimes used interchangeably and are not distinguished universally in the way a simplified glossary may imply.\n\n#### Unexpected Biological Relationships (Misattributed Parentage)\n\nA situation in which genetic testing reveals that an assumed biological relationship is not the biological relationship.\n\nUse it precisely: prefer neutral language such as \"unexpected biological relationship\" or \"misattributed parentage.\" Consent, confidentiality, and laboratory policy matter, and there is no single universal disclosure rule. The counseling task is to understand the policy, the family's context, and the person's preferences.\n\n### Penetrance and Expressivity: A Summary\n\nConcept |\nWorking definition |\nTeaching example |\n\nPenetrance |\nProportion of genotype carriers who show a defined phenotype in a defined population and time frame |\nHypothetical example: By age 40, 80 of 100 people with a specified genotype meet the defined clinical criteria; penetrance for that phenotype by that age is 80% |\n\nExpressivity |\nVariation in the type and severity of findings among affected people |\nNeurofibromatosis type 1: café-au-lait macules only versus plexiform neurofibromas |\n\nFor condition-specific risk figures, use a dated source and state the phenotype, age range, and population. A single lifetime number for a gene such as BRCA1 is not a complete risk statement; see BRCA1 and BRCA2 GeneReviews (https://www.ncbi.nlm.nih.gov/books/NBK1247/) for the current discussion.\n\n### Using This Glossary for Board Preparation\n\nThese terms support both genetic counseling and medical genetics reasoning. Reading definitions is not enough — you need to apply them to unfamiliar vignettes. Use the current official ABGC or ABMGG outline to define your examination scope, then practice explaining why the closest alternative does not fit.\n\nContinue with inheritance patterns (https://every-gene.academy/articles/genetics-inheritance-patterns-guide/) , variant interpretation practice (https://every-gene.academy/practice/abgc-questions/) , or the medical genetics sample questions (https://every-gene.academy/practice/medical-genetics-questions/) .\n\nSelected sources: ClinGen PVS1 recommendations (https://pubmed.ncbi.nlm.nih.gov/30192042/) ; GeneReviews mosaicism (https://www.ncbi.nlm.nih.gov/books/NBK585455/) ; MedlinePlus penetrance and expressivity (https://medlineplus.gov/genetics/understanding/inheritance/penetranceexpressivity/) ; NHGRI frameshift definition (https://www.genome.gov/genetics-glossary/Frameshift-Mutation) ; GeneReviews glossary (https://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/) . Definitions are introductory and do not replace clinical guidance."
    },
    {
      "type": "article",
      "title": "Inheritance Patterns: A Clinical and Board Review Guide",
      "url": "https://every-gene.academy/articles/genetics-inheritance-patterns-guide/",
      "description": "Review inheritance patterns for genetics board prep, including autosomal, X-linked, and mitochondrial examples. Practice recurrence risk and pedigree reasoning.",
      "author": "EveryGene",
      "published": "2026-11-04",
      "updated": "2026-11-06",
      "text": "Inheritance patterns matter for both genetic counseling and medical genetics reasoning: they shape recurrence risk, who should be offered testing, and how a result is explained to a family. The patterns below are teaching models. Real families often require condition-specific information, penetrance estimates, and test results before a risk can be given.\n\nIf you want a worked pedigree calculation first, start with the pedigree practice guide (https://every-gene.academy/guides/pedigree-practice-problems/) . For written practice, the free Pedigree Workbook (https://www.every-gene.com/pedigree-workbook) is a companion resource.\n\n### Autosomal Dominant (AD) Inheritance\n\nCore features under a simple model:\n\n- An affected heterozygous parent has a 1/2 probability of transmitting the variant with each pregnancy.\n\n- Males and females can be affected.\n\n- A variant can appear in successive generations, but not every dominant condition appears in every generation.\n\n- An unaffected person can carry and transmit a variant when penetrance is reduced or onset is age-related.\n\nConditions often used to teach AD concepts: Huntington disease, Marfan syndrome, neurofibromatosis type 1, achondroplasia, familial hypercholesterolemia, and some hereditary cancer syndromes such as BRCA1/2-associated cancer.\n\nImportant qualifications:\n\n- Penetrance is the proportion of people with a genotype who show the phenotype. An unaffected carrier is possible when penetrance is incomplete.\n\n- Variable expressivity describes different severity among affected people with the same variant.\n\n- Anticipation describes earlier onset or greater severity in successive generations for some repeat-expansion disorders, such as Huntington disease. It is not a general feature of all dominant conditions.\n\n- De novo variants are common in some severe dominant conditions and can explain an affected child with unaffected parents.\n\n- Clinical expression is not identical across sexes. BRCA1/2-associated cancer risk is a clear example: a simple statement that males and females are affected \"equally\" would be misleading.\n\nTransmission probability and clinical outcome are separate questions. An affected parent may have a 1/2 chance of transmitting a variant, while the chance of clinical disease also depends on penetrance and other factors.\n\n### Autosomal Recessive (AR) Inheritance\n\nCore features under a simple model:\n\n- Disease typically requires biallelic pathogenic variants in the same gene. The variants may be homozygous (the same variant on both copies) or compound heterozygous (different pathogenic variants, one on each copy), with the variants in trans where relevant.\n\n- Males and females can be affected.\n\n- Carrier parents are typically unaffected.\n\n- A family may appear to \"skip\" generations because carriers are unaffected.\n\nConditions often used to teach AR concepts: cystic fibrosis, sickle cell disease, phenylketonuria, Tay-Sachs disease, spinal muscular atrophy, and GJB2-related hearing loss.\n\nImportant qualifications:\n\n- Consanguinity increases the chance that both partners carry the same recessive variant.\n\n- Carrier frequency differs by condition and population. Population labels are approximations, not individual risk estimates.\n\n- Not all recessive disease is caused by two identical variants, and not every variant in a recessive gene is pathogenic.\n\n#### Recurrence risk table for a simple AR model\n\nThis table describes a simplified model with full penetrance and relevant pathogenic variants in the same gene. It is a teaching model, not a substitute for family-specific counseling.\n\nParental genotypes |\nAffected child probability |\nOther offspring outcomes |\n\nAa and Aa |\n25% |\n50% carriers and 25% noncarriers |\n\naa and AA |\n0% |\nAll carriers |\n\naa and Aa |\n50% |\n50% carriers |\n\naa and an untested, unaffected partner (AA or Aa) |\nPartner carrier probability × 1/2 |\nAssumes full penetrance and excludes an affected partner |\n\nThe last row models the unaffected partner as AA or Aa under full penetrance. If an affected partner is also possible, the general affected-child probability is P(partner Aa)/2 + P(partner aa). An unrelated partner is not automatically a noncarrier. If the partner's carrier probability is unknown, incorporate it rather than treating it as zero. For the same recessive condition, aa × AA produces no affected children and all carriers under the simple model; aa × Aa produces a 50% chance of an affected child and a 50% chance of a carrier.\n\n#### Unaffected sibling of an affected child\n\nFor two confirmed carrier parents, the possible offspring genotypes are AA, Aa, aA, and aa. If the sibling is known to be unaffected, aa is excluded. Two of the three remaining outcomes are carriers:\n\nCarrier probability = 2/3\n\nThat conditional probability belongs to the unaffected sibling, not to the already confirmed carrier parents. Confirmed carrier parents are carriers. This is the distinction that matters in pedigree questions.\n\nFor Aa × Aa, the outcomes are 25% affected, 50% unaffected carriers, and 25% unaffected noncarriers. Both carrier and noncarrier groups are unaffected under this model.\n\n### X-Linked Inheritance\n\nX-linked inheritance is often taught as two tidy categories. Real conditions are more variable, and several commonly used examples need condition-specific explanations.\n\n#### X-Linked Recessive (XLR)\n\nCore features under a simple model:\n\n- Males with a pathogenic variant on their single X chromosome are affected.\n\n- Females with one pathogenic variant are carriers and are often unaffected, but can manifest symptoms due to skewed X-inactivation.\n\n- A carrier mother has a 1/2 chance of transmitting the variant to each child. Sons who inherit it are affected; daughters who inherit it are carriers.\n\n- An affected father does not transmit an X-linked variant to his sons.\n\n- There is no father-to-son transmission of an X-linked variant.\n\nConditions often used to teach XLR concepts: hemophilia A and B, Duchenne and Becker muscular dystrophy, G6PD deficiency, and color vision deficiency.\n\nQualification: an affected father's son can still be affected through a maternal contribution or a different cause. The absence of father-to-son transmission applies to the X-linked variant, not to every possible explanation for a similar phenotype in the son.\n\n#### X-Linked Dominant (XLD)\n\nCore features under a simple model:\n\n- A heterozygous mother has a 50% probability of transmitting the X-linked variant in each pregnancy.\n\n- An affected father transmits the variant to all daughters and no sons under the usual XX/XY model. Whether an inheriting child manifests the condition depends on the disorder and other relevant factors.\n\n- Expression can differ by sex, and male lethality can occur in specific conditions.\n\nQualification: daughters who inherit a paternal X-linked variant do not invariably have the same clinical outcome. State which parent carries which variant, and distinguish inheriting the variant from manifesting the disorder.\n\n#### Conditions that do not fit a simple X-linked label\n\n- Fragile X syndrome (FMR1). Inheritance depends on repeat size and parent of origin. Premutation carriers can have different risks than full-mutation carriers, and the phenotype differs by sex. Treating fragile X as a straightforward X-linked recessive or dominant condition obscures the counseling.\n\n- MECP2 duplication syndrome. Inheritance is X-linked, but many mothers who carry the duplication are clinically unaffected heterozygotes. The condition is not a simple \"all daughters of affected males are affected\" example.\n\n- Incontinentia pigmenti. The disorder is typically male-lethal, but affected males can survive in specific settings, including mosaicism or 47,XXY. Typical male lethality is not an exception-free rule.\n\nThe FMR1-related disorders (https://www.ncbi.nlm.nih.gov/books/NBK1384/) and MECP2 duplication (https://www.ncbi.nlm.nih.gov/books/NBK1284/) GeneReviews chapters are better starting points than a category label.\n\n### Mitochondrial Inheritance\n\nCore features for mtDNA variants:\n\n- Human mitochondrial DNA is ordinarily maternally inherited.\n\n- A mother with a pathogenic mtDNA variant can transmit it to her children, but the outcome is not identical in every child.\n\n- Heteroplasmy — the coexistence of variant and wild-type mtDNA — and tissue distribution influence severity. Higher variant levels are not a universal severity formula across people, tissues, variants, and disorders.\n\n- An affected father does not ordinarily transmit an mtDNA variant to his children.\n\nConditions often used to teach mitochondrial concepts: MELAS, MERRF, Leber hereditary optic neuropathy, and single large-scale mtDNA deletion syndromes.\n\nImportant qualifications:\n\n- Kearns-Sayre syndrome belongs among the single large-scale mtDNA deletion syndromes, which usually arise de novo. It is a poor unqualified example of a multigenerational maternal pedigree.\n\n- Not all mitochondrial disease is mtDNA disease. Many mitochondrial disorders are caused by nuclear genes and follow Mendelian inheritance. A syndrome name alone does not establish maternal inheritance or heteroplasmy.\n\n- A heteroplasmic mother's children are at risk, but transmission of a particular variant and clinical severity are not guaranteed to be identical in every child.\n\n### Y-Linked Inheritance\n\nUnder an explicit model, a variant on the Y chromosome is transmitted from an affected father to all sons and no daughters. Very few conditions are truly Y-linked.\n\nY-chromosome infertility is a reproductive-genetics example rather than a simple multigenerational pedigree: variants in the AZF regions can affect spermatogenesis, and the reproductive context matters. Do not imply that ordinary father-to-son transmission of an infertility phenotype is assured.\n\n### Pedigree Interpretation: A Framework\n\nWhen a pedigree appears in a question, work through the information in a consistent order:\n\n- List affected people and their sex. Note ages and any known diagnoses.\n\n- Describe the transmission pattern. Vertical and horizontal patterns are clues, not proof.\n\n- Check for father-to-son transmission. Confirmed transmission of the same causal X-linked allele from father to son would exclude X-linked inheritance for that allele.\n\n- Look for consanguinity. A loop can raise AR risk, but it does not establish the diagnosis.\n\n- Consider penetrance, age at onset, mosaicism, and de novo variants. These are limits on a pedigree shortcut, not rare exceptions to ignore.\n\n- Calculate the probability the question asks for. Name whether you are estimating transmission, carrier status, or clinical disease.\n\nA small family can fit more than one pattern. Visual resemblance alone does not establish that a child inherited the same causal allele from a parent.\n\n### Apply inheritance reasoning to your exam preparation\n\nUse the current official ABGC or ABMGG outline to plan your coverage. For each inheritance pattern, practice identifying the relevant family information and calculating the outcome the question asks about.\n\nContinue with pedigree practice and conditional risk (https://every-gene.academy/guides/pedigree-practice-problems/) , Bayesian risk (https://every-gene.academy/guides/genetics-probability-bayesian-risk/) , and the free Pedigree Workbook (https://www.every-gene.com/pedigree-workbook) .\n\nSelected sources: MedlinePlus inheritance risk assessment (https://medlineplus.gov/genetics/understanding/inheritance/riskassessment/) ; GeneReviews on incontinentia pigmenti (https://www.ncbi.nlm.nih.gov/books/NBK1472/) and primary mitochondrial disorders (https://www.ncbi.nlm.nih.gov/books/NBK1224/) ; NCI X-linked dominant inheritance (https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/x-linked-dominant-inheritance) . The risk table is an original teaching calculation under the stated model."
    },
    {
      "type": "article",
      "title": "ABGC Exam Planning: A Practical Study Plan",
      "url": "https://every-gene.academy/articles/how-to-prepare-for-abgc-board-exam/",
      "description": "Plan ABGC board preparation with the official content outline, an adaptable study schedule, and practice strategies focused on reviewing question explanations.",
      "author": "EveryGene",
      "published": "2026-11-04",
      "updated": "2026-11-06",
      "text": "The ABGC examination is a major step in a genetic counselor's professional preparation. Preparing well means knowing the scope of the examination, choosing resources that match the task, and reviewing your practice results instead of simply accumulating questions.\n\nUse this worksheet and calendar to plan your study time. For the practice, explanation-review, and retrieval steps inside each session, use the ABGC board exam study guide (https://every-gene.academy/guides/abgc-board-exam-study-guide/) .\n\n### What the ABGC Exam Covers\n\nThe examination is computer-based and currently contains 200 questions with four hours of testing time. Of those, 170 are scored and 30 are pretest items.\n\nUse the current ABGC content outline (https://www.abgc.net/Diplomate-Resources/Program-Director-Resources) as your map. The outline linked at the time of this review has five domains:\n\n- Clinical and developmental information — genetics knowledge applied to clinical presentations and development\n\n- Risk and human genetics — inheritance, probability, and risk assessment\n\n- Testing and reproductive risk — test selection, interpretation, and reproductive considerations\n\n- Counseling and education — communication, psychosocial considerations, and client education\n\n- Professional, legal, resource, and reimbursement topics — ethics, professional practice, and access to care\n\nThe currently linked outline PDF (https://www.abgc.net/Portals/0/2023%20CGC%20Exam%20Content%20Outline.pdf) supplies the detailed scope. Domain labels and emphasis can change. Always use the version currently linked by ABGC rather than a summary from a prep guide.\n\n### Build the Plan Around Your Real Timeline\n\nThere is no single required preparation period. The right timeline depends on your baseline, your examination date, your clinical schedule, and the hours you can protect each week.\n\nThis calendar is an adaptable planning example, not a validated program. An illustrative 12-week structure might look like this:\n\n#### Weeks 1–2: Establish a baseline\n\n- Read the current content outline and mark your confidence in each area.\n\n- Complete a manageable mixed question set.\n\n- Record incorrect answers and correct answers that involved guessing.\n\n#### Weeks 3–7: Focused review\n\n- Work through the domains where your baseline and practice results show gaps.\n\n- Choose question sets small enough that you can review the explanations thoroughly.\n\n- For calculation or pedigree gaps, use the free Genetics Math Workbook (https://www.every-gene.com/math-workbook) or Pedigree Workbook (https://www.every-gene.com/pedigree-workbook) .\n\n#### Weeks 8–10: Mixed application\n\n- Increase the proportion of mixed and timed practice.\n\n- Review why the closest alternative did not fit, not only why the correct answer was correct.\n\n- Revisit earlier corrections without looking at the answer first.\n\n#### Weeks 11–12: Consolidation\n\n- Reduce the introduction of new material and protect sleep.\n\n- Review persistent weak spots and practice under the timing you expect to use.\n\n- Confirm exam-day logistics with ABGC and the testing provider.\n\nIf you have fewer than 12 weeks, reassess how much material you need to cover and how many study hours you can realistically protect. A shorter preparation period may require more study time each week or a more focused approach to established weaknesses. Preserve time for explanation review, repeated retrieval, and mixed practice. If your available time does not accommodate the remaining material, reconsider your examination timeline where possible.\n\n### Fill In Your Planning Worksheet\n\nCopy this table into your calendar before choosing your first week's sessions. Set the session length around the time available for both answering and review.\n\nPlanning decision |\nYour entry |\n\nExamination date and application deadline |\n______ |\n\nWeeks available and planned days off |\n______ |\n\nRealistic study windows each week |\n______ |\n\nOfficial outline areas needing the most attention |\n______ |\n\nPrimary question resource and reference source |\n______ |\n\nWeekly progress check and catch-up window |\n______ |\n\nDate to confirm testing arrangements |\n______ |\n\n#### Example weekly study schedule\n\nThe following example provides approximately 12 hours of study per week, with one full rest day. It illustrates how someone preparing over approximately 12 weeks might organize study alongside work or other commitments. Adjust the workload to your starting knowledge, examination date, and progress through the official content outline.\n\nDay |\nPlanned study time |\nHow to use the time |\n\nMonday |\n2 hours |\nReview a priority topic from the official content outline, then answer related practice questions. Review the explanations and record concepts that need another look. |\n\nTuesday |\n2 hours |\nComplete targeted EveryGene Academy (https://app.every-gene.academy/) questions and review the reasoning behind your answers, including correct guesses. Use part of the session for condition retrieval with the original 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) . |\n\nWednesday |\n2 hours |\nStudy a second priority topic. Connect the content with clinical or counseling examples, then use practice questions to check whether you can apply it. |\n\nThursday |\n1 hour |\nWork through calculations or pedigree problems using the free Genetics Math Workbook (https://www.every-gene.com/math-workbook) or Pedigree Workbook (https://www.every-gene.com/pedigree-workbook) . Write out your reasoning, review errors, and retry selected problems without looking at the solutions. |\n\nFriday |\n2 hours |\nComplete a mixed practice set, introducing timing when appropriate. Review incorrect answers and uncertain responses, and identify whether each difficulty involved knowledge, interpretation, calculations, or pacing. |\n\nSaturday |\n3 hours, split into two sessions |\nRevisit the week’s difficult concepts and apply them to fresh questions. Retrieve material from earlier weeks so it stays in your review cycle. Use the final 15 minutes to check outline coverage and plan the next week. |\n\nSunday |\nRest |\nTake a planned break from studying. Move this rest day if another day fits your commitments better. |\n\nThe question-answering and explanation-review time should both fit within each study block. Choose a manageable number of questions so you can understand the reasoning, rather than rushing to meet a daily quota.\n\nBrief flashcard or recall sessions can help reinforce material between longer sessions. They complement the time spent learning content and working through questions.\n\nAt the weekly check, assess what you can explain and apply without your notes. If important outline areas remain unfamiliar or the same errors keep recurring, adjust your priorities, weekly study time, or preparation timeline. Completing the calendar alone does not establish examination readiness.\n\nFor the steps inside each practice session, use the ABGC practice-review-retrieval workflow (https://every-gene.academy/guides/abgc-board-exam-study-guide/) and the missed-question review guide (https://every-gene.academy/guides/review-missed-genetics-questions/) .\n\n### Practice and Learning Research\n\nRetrieval practice and spaced practice have experimental support in the settings studied. Put them into practice by answering before checking the explanation and revisiting material over time. These studies did not evaluate EveryGene Academy or its examination outcomes. See Roediger and Karpicke (2006) (https://pubmed.ncbi.nlm.nih.gov/16507066/) and Cepeda and colleagues (2008) (https://pubmed.ncbi.nlm.nih.gov/19076480/) .\n\nA practical translation:\n\n- Answer before looking at the explanation.\n\n- Revisit earlier topics rather than studying each topic once.\n\n- Use unfamiliar questions to check whether a concept transfers.\n\n- Treat practice scores as information about your preparation, not as a predicted pass/fail result.\n\n### The Official Outline Is Not a High-Yield List\n\nA list of commonly tested topics is not the same as the official domain structure. Clinically important topics are worth learning, but importance does not establish how often a topic appears on a confidential examination.\n\nUse the official outline to make sure you have covered the scope. Use practice results to decide where to spend the next session. Use topic lists as study prompts alongside the full outline.\n\n### Managing Exam Anxiety\n\nAnxiety before a high-stakes examination is normal. Useful strategies include:\n\n- Practicing under the timing you expect to use, so the format is familiar.\n\n- Deciding in advance how you will handle a question that takes too long.\n\n- Protecting sleep and physical activity during the final weeks.\n\n- Using your practice record as evidence of what you have covered, rather than relying on how prepared you feel on a given day.\n\n### Where EveryGene Fits\n\nEveryGene Academy is a genetics question bank for genetic counseling learners preparing for ABGC and medical genetics learners preparing for ABMGG. It includes shared core genetics plus ABGC-focused and ABMGG-focused content, detailed explanations, timed and untimed practice, topic filters, and a performance dashboard.\n\nStart with the free ABGC-style sample questions (https://every-gene.academy/practice/abgc-questions/) if you want to see the format before choosing a plan.\n\nLast reviewed: November 2026. Sources: ABGC outline resources (https://www.abgc.net/Diplomate-Resources/Program-Director-Resources) ; candidate guide resources (https://www.abgc.net/CERTIFY/About-the-CGC-Credential) ; retrieval practice research (https://pubmed.ncbi.nlm.nih.gov/16507066/) ; spacing research (https://pubmed.ncbi.nlm.nih.gov/19076480/) . Practice scores do not predict examination performance."
    },
    {
      "type": "guide",
      "title": "ABMGG Clinical Genetics and Genomics Board Exam Study Guide",
      "url": "https://every-gene.academy/guides/abmgg-clinical-genetics-study-guide/",
      "description": "Organize Clinical Genetics and Genomics board preparation around official ABMGG outlines, case-based questions, focused review, and genetics study resources.",
      "author": "EveryGene",
      "updated": "2026-11-06",
      "text": "Use the current ABMGG requirements and content outlines to define your examination scope, then practice making the decisions a clinical vignette requires. Build a plan that covers both familiar clinic presentations and topics you encounter less often in training.\n\n### Confirm the examination you are preparing for\n\nBegin with the current ABMGG content outlines and blueprints (https://www.abmgg.org/initial-certification/content-outlines-and-blueprints/) and the board's current requirements for your certification pathway. This guide focuses on Clinical Genetics and Genomics. Laboratory genetics and medical biochemical genetics are separate specialty examinations with their own outlines. General examination and specialty requirements can change, so check the applicable cycle rather than relying on a previous trainee's schedule or an old preparation guide.\n\nUse the outline to make a coverage checklist. Include clinical presentation, disease mechanism, inheritance, test selection, interpretation, and management principles where relevant. A condition is not fully reviewed just because you recognize its name.\n\n### Turn cases into decisions\n\nFor each practice vignette, name the task before choosing an answer. Is the question asking for the diagnosis, the next test, the interpretation of a result, a recurrence risk, or a management principle? Write down the clue that most strongly separates your leading options.\n\nUse EveryGene Academy (https://app.every-gene.academy/) for focused and mixed question practice. The 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) can support condition review between sessions. For difficult calculations, use the free Math Workbook (https://www.every-gene.com/math-workbook) ; for family-history reasoning, use the free Pedigree Workbook (https://www.every-gene.com/pedigree-workbook) .\n\n### Review beyond the correct letter\n\nIf you recognized a syndrome but chose the wrong test, review test capability rather than spending the whole session rereading the syndrome. If the error involved a changing clinical recommendation, check an up-to-date guideline or condition-specific reference. Keep a short list of concepts to retrieve again later.\n\nAdd timed mixed sets when you can explain the reasoning in focused practice. A repeated question may feel easy because you remember it; use unfamiliar examples to check whether you can transfer the concept.\n\n### Practice a test-selection vignette\n\nA four-year-old child has unexplained global developmental delay, dysmorphic features, and congenital heart disease. Chromosomal microarray is normal. Clinical evaluation has not identified a recognizable syndrome or a specific repeat-expansion, methylation, or biochemical disorder. Both biological parents are available for testing. Which broad genetic testing approach should be considered next?\n\nModel answer: Consider trio exome or genome sequencing after counseling about its scope, limitations, and possible results. The ACMG pediatric ES/GS guideline (https://www.nature.com/articles/s41436-021-01242-6) supports exome or genome sequencing as a first- or second-tier test for children with congenital anomalies, developmental delay, or intellectual disability. This case fits that population and leaves a broad sequence-level differential after microarray.\n\nNearest alternative: A targeted gene panel may be appropriate when the phenotype points to a defined group of disorders. Here, the nonspecific findings favor broader testing. A normal microarray alone does not dictate the next test: a phenotype suggesting an imprinting disorder or repeat expansion would call for an assay that evaluates that mechanism. Review the test-selection guide (https://every-gene.academy/guides/genetic-test-selection/) to match the suspected mechanism to assay capability.\n\n### Keep the scope clear\n\nClinical genetics preparation is distinct from laboratory genetics or medical biochemical genetics specialty preparation. Use the relevant official outline for each examination. EveryGene is an independent study resource and does not supply official ABMGG examination questions.\n\nNext step: Try medical genetics practice questions (https://every-gene.academy/practice/medical-genetics-questions/) and review how to choose genetic tests (https://every-gene.academy/guides/genetic-test-selection/) .\n\nCheck the current requirements for your examination cycle, and use practice results to choose your next review topic."
    },
    {
      "type": "guide",
      "title": "Developmental Genetics Practice Questions",
      "url": "https://every-gene.academy/guides/developmental-genetics-practice/",
      "description": "Review developmental mechanisms with worked cases on malformation, deformation, disruption, and the difference between a sequence and a diagnosis.",
      "author": "EveryGene",
      "updated": "2026-11-06",
      "text": "Connect a developmental finding with how it arose. Before searching for a syndrome name, ask whether the case describes altered formation, a mechanical effect, tissue damage, or several findings linked by a developmental sequence.\n\n### Use developmental terms precisely\n\nTerm |\nTeaching definition |\n\nMalformation |\nA structural difference arising during initial formation |\n\nDeformation |\nA change in form or position associated with mechanical forces |\n\nDisruption |\nLoss or interference with a structure that had initially developed normally |\n\nDysplasia |\nAbnormal organization of tissue or cells within a structure |\n\nSequence |\nMultiple effects arising through a cascade from an initial problem |\n\nThese terms describe developmental relationships. They do not, by themselves, establish a molecular cause or a recurrence risk.\n\n### Case 1: A mechanical change after formation\n\nAn infant's foot is held in an abnormal position after prolonged intrauterine constraint. The case specifies that the foot initially formed normally and that the later change resulted from mechanical forces. Which developmental term best describes this change?\n\n- Malformation\n\n- Deformation\n\n- Disruption\n\n- Dysplasia\n\nAnswer: B. A deformation is an alteration in shape or position caused by mechanical forces after initial formation. A malformation arises during formation; a disruption involves damage to a structure that had initially developed normally; dysplasia concerns abnormal tissue organization. The stated mechanism, rather than the appearance alone, determines the best answer.\n\nSources: CDC terminology and classification, Appendix C (https://archive.cdc.gov/www_cdc_gov/ncbddd/birthdefects/surveillancemanual/appendices/appendix-c.html) ; CDC renal agenesis/hypoplasia discussion (https://archive.cdc.gov/www_cdc_gov/ncbddd/birthdefects/surveillancemanual/quick-reference-handbook/renal-agenesis-hypoplasia.html) .\n\n### Case 2: One initiating problem, several consequences\n\nA fetus has bilateral renal agenesis, followed by severe oligohydramnios, pulmonary hypoplasia, and limb contractures. The question asks how the renal finding and its downstream effects relate to one another. Which description best fits?\n\n- Several unrelated malformations with no developmental relationship\n\n- An association in which no causal cascade is established\n\n- A sequence initiated by the renal abnormality\n\n- A dysplasia affecting the organization of one tissue\n\nAnswer: C. In this example, the renal abnormality reduces fetal urine contribution to amniotic fluid. The resulting oligohydramnios contributes to the later pulmonary and positional findings. This is a sequence: related consequences follow an initiating abnormality. Calling the pattern a sequence does not establish why the kidneys failed to form or supply a recurrence risk. The initiating malformation and the downstream sequence are descriptions at different levels.\n\nSources: CDC terminology and classification, Appendix C (https://archive.cdc.gov/www_cdc_gov/ncbddd/birthdefects/surveillancemanual/appendices/appendix-c.html) ; CDC renal agenesis/hypoplasia discussion (https://archive.cdc.gov/www_cdc_gov/ncbddd/birthdefects/surveillancemanual/quick-reference-handbook/renal-agenesis-hypoplasia.html) .\n\n### Link the mechanism to the next question\n\nAfter identifying the developmental relationship, ask what the case gives you about etiology, associated findings, and family history. Avoid assigning a recurrence risk from a descriptive term alone. The same visible finding can arise through different mechanisms.\n\nUse EveryGene Academy (https://app.every-gene.academy/) for additional application. The 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) support condition review; use the free pediatric workbook (https://www.every-gene.com/pediatric-workbook) .\n\nSource: CDC Birth Defects Surveillance Toolkit terminology glossary (https://archive.cdc.gov/www_cdc_gov/ncbddd/birthdefects/surveillancemanual/resource-library/glossary.html) . The examples illustrate definitions rather than provide patient-specific diagnostic rules."
    },
    {
      "type": "guide",
      "title": "Build a Genetics Board Study Schedule",
      "url": "https://every-gene.academy/guides/genetics-board-study-schedule/",
      "description": "Create a realistic genetics study schedule with question practice, explanation review, flashcards, and room for busy weeks during school or residency.",
      "author": "EveryGene",
      "updated": "2026-11-06",
      "text": "Start with the time you can consistently protect, then assign a purpose to each session. A study calendar is useful when it helps you return to important concepts; it becomes less useful when one missed evening makes the whole plan feel unworkable.\n\n### Define the scope and the available time\n\nStart with the current ABGC content outline resources (https://www.abgc.net/Diplomate-Resources/Program-Director-Resources) or ABMGG content outlines and blueprints (https://www.abmgg.org/initial-certification/content-outlines-and-blueprints/) for your examination. List the weeks until your exam and identify call weeks, rotations, travel, or other predictable constraints. Schedule lighter work in the busiest periods rather than assuming every week will look the same.\n\n### Give each session a clear job\n\nBuild your week around study blocks that allow time for content review, practice questions, and thorough explanation review. Include retrieval of material from previous weeks, written calculation or pedigree practice where needed, and a planned rest or catch-up period. Short recall sessions can reinforce this work between longer sessions. For one possible allocation of study time, see the example weekly calendar (https://every-gene.academy/articles/how-to-prepare-for-abgc-board-exam/#example-weekly-study-schedule) in our ABGC planning article.\n\n- In a focused session, use EveryGene Academy (https://app.every-gene.academy/) to practice one weak area and review the explanations.\n\n- In a mixed session, practice recognizing what kind of problem you are being asked to solve.\n\n- In a retrieval session, use the 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) or revisit a short list of previous mistakes without looking at your notes first.\n\nFor math and family-history gaps, replace a general review session with the free Math Workbook (https://www.every-gene.com/math-workbook) or Pedigree Workbook (https://www.every-gene.com/pedigree-workbook) . For pediatric cases, use the free pediatric workbook (https://www.every-gene.com/pediatric-workbook) .\n\n### Work backward from the time available\n\nBegin by comparing your examination date, available study hours, and remaining coverage of the relevant official outline. Reserve time for baseline assessment, focused review, and later mixed practice. If the preparation period becomes shorter, reassess the weekly workload rather than simply compressing the calendar. Your plan should leave enough time to review explanations and revisit difficult concepts.\n\n### Recover from a missed week\n\nResume with your highest-priority gap and one mixed set. Reduce the size of the next session if needed. Preserve time for explanation review instead of trying to repay every missed question. Your schedule should reflect what your results show you need now.\n\nNext step: Choose your next three study sessions and give each one a specific purpose.\n\nSource context: Distributed practice research supports revisiting material over time; these studies do not establish EveryGene examination outcomes. See Cepeda et al. 2008, PMID 19076480 (https://pubmed.ncbi.nlm.nih.gov/19076480/) ."
    },
    {
      "type": "guide",
      "title": "Genetics Probability and Bayesian Risk Problems",
      "url": "https://every-gene.academy/guides/genetics-probability-bayesian-risk/",
      "description": "Learn to combine carrier probabilities and update risk after a negative test with worked genetics examples and a free math workbook.",
      "author": "EveryGene",
      "updated": "2026-11-06",
      "text": "Before calculating, name the event you are trying to estimate. \"Carries the variant,\" \"has the condition,\" and \"has a negative result\" are different events. Many errors begin when a correct number is attached to the wrong question.\n\n### Multiply independent steps for a joint event\n\nTwo unaffected partners have carrier probabilities of 1/5 and 1/20 for the same fully penetrant autosomal recessive condition. Model each partner as AA or Aa and assume their carrier risks are independent. The probability of an affected child is:\n\n1/5 × 1/20 × 1/4 = 1/400 per pregnancy\n\nThe first two factors estimate the chance both are carriers; the last estimates an affected child if both are carriers. Relatedness or other shared information can make an independence assumption inappropriate.\n\n### Update the prior after a negative test\n\nFor an illustrative assay, assume a prior carrier probability of 1/20, sensitivity of 95%, and specificity of 100%. A negative result can occur in a carrier whom the assay misses or in a noncarrier.\n\n- Carrier and negative: 1/20 × 1/20 = 1/400\n\n- Noncarrier and negative: 19/20 × 1 = 380/400\n\n- Residual carrier probability among negative results: 1/(1 + 380) = 1/381\n\nThe 5% false-negative rate is not the residual carrier probability. The posterior also depends on how likely carrier status was before testing. These assay values are hypothetical and should not be transferred to a real laboratory test.\n\nBranch |\nProbability |\nWhat it represents |\n\nCarrier and negative |\n1/20 × 1/20 = 1/400 |\nCarriers whom the assay missed |\n\nNoncarrier and negative |\n19/20 × 1 = 380/400 |\nTrue noncarriers with a negative result |\n\nPosterior among negatives |\n1 ÷ (1 + 380) = 1/381 |\nCarrier branch divided by the total negative branch |\n\n### Use a general expression when helpful\n\nPosterior carrier probability after a negative result:\n\n[Prior × (1 − sensitivity)] ÷ {[Prior × (1 − sensitivity)] + [(1 − prior) × specificity]}\n\nUse this only when the stated test model fits the problem. Real residual-risk estimates may depend on the condition, assay, ancestry data, and laboratory reporting conventions.\n\n### Practice the setup before increasing speed\n\nLabel each branch before entering numbers. After solving, ask whether the result is plausible: under the model above, a negative result should lower carrier risk without making it zero. Use the free Genetics Math Workbook (https://www.every-gene.com/math-workbook) for written practice and EveryGene Academy (https://app.every-gene.academy/) for case-based application.\n\nSee also: Hardy-Weinberg practice problems (https://every-gene.academy/guides/hardy-weinberg-practice/) and pedigree practice problems (https://every-gene.academy/guides/pedigree-practice-problems/) ."
    },
    {
      "type": "guide",
      "title": "Hereditary Cancer Genetics Practice Cases",
      "url": "https://every-gene.academy/guides/hereditary-cancer-genetics-practice/",
      "description": "Practice interpreting family cancer history, selecting an informative person to test, and distinguishing true from uninformative negative results.",
      "author": "EveryGene",
      "updated": "2026-11-06",
      "text": "In a hereditary cancer vignette, connect the personal and family history with the testing question. Identifying a familiar cancer-gene association is useful, but the case may instead ask who to test or how to interpret a negative result.\n\n### Build the family context\n\nNote the cancer types, ages at diagnosis, relationships, and which side of the family is involved. Identify whether a familial pathogenic variant has already been established. A family-history pattern and a confirmed molecular result provide different kinds of information.\n\nWhen possible, testing a person with a relevant cancer can be more informative than beginning with an unaffected relative. The best available person and the appropriate test still depend on the full history and clinical context.\n\n### Practice case: A negative panel in an unexplained family\n\nAn unaffected 36-year-old woman has a negative hereditary cancer panel. Her mother had breast cancer at 39 and her maternal aunt had ovarian cancer at 47. Both affected relatives are living and have not had genetic testing. No familial pathogenic variant is known. Which interpretation and next step are most appropriate?\n\n- Treat the result as a true negative and base screening on population risk.\n\n- Attribute the family history to polygenic risk and close the hereditary assessment.\n\n- Use personal and family history to guide care and consider testing an affected relative.\n\n- Treat the family as having confirmed BRCA1-related disease and use variant-specific family testing.\n\nAnswer: C. This result may be an uninformative negative. Without an established familial variant, it does not resolve the family history. Testing an affected relative may be more informative. A overinterprets the negative result; B assigns an unproven explanation; D assumes a specific molecular diagnosis that has not been established.\n\nNCI genetic testing fact sheet (https://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-testing-fact-sheet)\n\n### Compare with a known familial variant\n\nIf a laboratory specifically evaluates a known familial pathogenic variant and does not find it, that negative result has a different interpretation from a negative panel in an unexplained family. It does not mean the person has no cancer risk from any cause. Keep the tested question and the broader clinical picture separate.\n\n### Practice interpretation rather than isolated gene lists\n\nCompare pathogenic or likely pathogenic findings, variants of uncertain significance, and negative results in their family context. For an uncertain finding, review the glossary's explanation of a variant of uncertain significance (https://every-gene.academy/articles/genetics-glossary-key-terms/#variant-of-uncertain-significance) . For questions about what an assay evaluated, use the genetic test selection guide (https://every-gene.academy/guides/genetic-test-selection/) .\n\nUse EveryGene Academy (https://app.every-gene.academy/) for case practice and the free Pedigree Workbook (https://www.every-gene.com/pedigree-workbook) for family-history reasoning. Explore the 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) for condition-focused review.\n\nSources: NCI BRCA testing fact sheet (https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet) ; BRCA1 and BRCA2 GeneReviews (https://www.ncbi.nlm.nih.gov/books/NBK1247/) ."
    },
    {
      "type": "guide",
      "title": "Pediatric Genetics Cases for ABGC and ABMGG",
      "url": "https://every-gene.academy/guides/pediatric-genetics-board-review/",
      "description": "Review pediatric genetics presentations and practice inheritance, clinical reasoning, and family-risk questions for ABGC and ABMGG preparation.",
      "author": "EveryGene",
      "updated": "2026-11-06",
      "text": "Organize genetics review around the presentations you encounter in pediatrics: developmental differences, growth concerns, congenital anomalies, metabolic emergencies, and hereditary cancer risk in families.\n\n### Connect the presentation with the mechanism\n\nFor each case type, ask whether the question is about recognition, test selection, interpretation, recurrence, or management. A condition name is not the same as understanding the mechanism and its implications for the family.\n\nUse condition-specific references such as GeneReviews for up-to-date evaluation and management information. Board preparation based only on memorized fact lists may not transfer to an unfamiliar presentation.\n\n### Practice case: A new diagnosis and future family risk\n\nA five-year-old child has multiple café-au-lait macules, axillary freckling, and a confirmed constitutional heterozygous pathogenic NF1 variant. The variant is not detected in either parent's blood. What is the probability that each future child of this patient would inherit the NF1 variant?\n\n- Close to zero because the variant was apparently de novo.\n\n- 25% because neither grandparent has the variant detected in blood.\n\n- 50% because the patient has a constitutional heterozygous autosomal dominant variant.\n\n- 100% because NF1 has high penetrance.\n\nAnswer: C. An apparently de novo origin does not remove the patient's ability to transmit the variant. Each future child has a 50% probability of inheriting it. High penetrance concerns clinical expression after inheritance; it does not make transmission certain. NF1 findings can vary considerably, so the parent's presentation does not predict the child's severity.\n\nNeurofibromatosis 1 GeneReviews (https://www.ncbi.nlm.nih.gov/books/NBK1109/)\n\nStudy takeaway: Separate how a variant arose from how it can be passed on. Identify the inheritance model before calculating risk.\n\nReview condition knowledge with the original 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) , then apply the concept in medical genetics practice questions (https://every-gene.academy/practice/medical-genetics-questions/) .\n\n### Use free resources as a starting point\n\nThe free Pediatric Genetics Workbook (https://www.every-gene.com/pediatric-workbook) offers board-style questions with explanations — a focused introduction to applying genetics concepts in pediatric case-based review. It is a genetics resource, not a complete pediatric board preparation course.\n\n### Connect pediatric cases with your genetics exam\n\nUse the current ABGC or ABMGG outline to decide which pediatric genetics concepts to review. Focus on the decision in each case: recognition, mechanism, test selection, interpretation, family risk, or management principles.\n\nFor calculation practice, use the free Math Workbook (https://www.every-gene.com/math-workbook) . For family-history interpretation, use the free Pedigree Workbook (https://www.every-gene.com/pedigree-workbook) . Apply these concepts in the shared core and exam-focused questions relevant to your preparation in EveryGene Academy (https://app.every-gene.academy/) .\n\nFree Pediatric Workbook → (https://www.every-gene.com/pediatric-workbook)\n\nPractice in EveryGene Academy → (https://app.every-gene.academy/)"
    },
    {
      "type": "guide",
      "title": "Pedigree Practice Problems and Recurrence Risk",
      "url": "https://every-gene.academy/guides/pedigree-practice-problems/",
      "description": "Practice inheritance reasoning with worked pedigree scenarios, conditional carrier risks, and a free genetics pedigree workbook.",
      "author": "EveryGene",
      "updated": "2026-11-06",
      "text": "Start by describing the family information before assigning an inheritance pattern. Note who is affected, relationships, ages where relevant, and whether a molecular diagnosis is known. A small family can fit more than one inheritance model.\n\n### Separate a pattern from a confirmed mechanism\n\nAffected people in successive generations may suggest dominant inheritance, but family structure alone does not prove the mechanism. Unaffected parents can have a child with a recessive condition, a de novo dominant condition, or another explanation. Use the vignette's explicit assumptions when calculating a board-style risk.\n\n### Worked example: a known dominant variant\n\nA heterozygous parent has a confirmed pathogenic variant causing an autosomal dominant condition. Their partner does not carry the variant. Assume full penetrance over the time horizon being considered. Each child has a 1/2 probability of inheriting the variant and, under this model, developing the associated phenotype.\n\nIn a different case, reduced penetrance or age-dependent onset can make the chance of clinical findings different from the chance of inheriting the variant. Identify which outcome and time horizon the question asks you to estimate.\n\n### Worked example: unaffected sibling and partner carrier risk\n\nAn unaffected adult woman has a brother with a fully penetrant autosomal recessive condition. Both parents are confirmed carriers. Her carrier probability is 2/3. Her unrelated, unaffected partner has a stated carrier probability of 1/30 for the same condition. Assume independent risks and the standard fully penetrant model.\n\n(https://every-gene.academy/assets/images/everygene-ar-carrier-risk-pedigree.svg)\n\nTwo confirmed carrier parents have an affected son and an unaffected daughter. The daughter's genotype is unresolved: among unaffected offspring, the carrier probability is 2/3. With an unrelated partner whose carrier probability is 1/30, the affected-child probability is 1/180 per pregnancy under the stated model. View the full-size pedigree (https://every-gene.academy/assets/images/everygene-ar-carrier-risk-pedigree.svg)\n\nTwo thirds multiplied by one thirtieth multiplied by one quarter gives one in one hundred eighty per pregnancy.\n\n2/3 × 1/30 × 1/4 = 1/180 per pregnancy\n\nThe 1/4 applies when both parents are carriers; it is not the starting probability for this couple. The 2/3 comes from conditioning on unaffected status among children of two carrier parents.\n\n### Worked example: an affected parent and an untested partner\n\nAn affected adult (aa) has a partner whose carrier probability is not established by testing. Under the simple model, the probability of an affected child depends on the partner's carrier probability:\n\n- If the partner is a carrier (Aa), the probability is 1/2, and half of the offspring would be carriers.\n\n- If the partner is not a carrier (AA), the probability is 0, and all offspring would be carriers.\n\n- If the untested partner is known to be unaffected under the fully penetrant model and is modeled as AA or Aa, multiply the partner's carrier probability by 1/2. If an affected partner is also possible, use P(partner Aa)/2 + P(partner aa). An unrelated partner is not automatically a noncarrier.\n\nClinical expression and penetrance are separate considerations. Under the simple model, the child may inherit a variant without manifesting disease when penetrance is incomplete; do not confuse inheriting a variant with having the condition.\n\n### Make your assumptions visible\n\nRecord whether the model assumes full penetrance, a known familial mechanism, independence, and no additional modifying information. If testing results or relationships change those assumptions, update the calculation. A pedigree is evidence to interpret, not a shortcut that replaces the rest of the case.\n\nUse the free Pedigree Workbook (https://www.every-gene.com/pedigree-workbook) for additional scenarios and the Math Workbook (https://www.every-gene.com/math-workbook) for written calculations. EveryGene Academy (https://app.every-gene.academy/) adds case-based application. The 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) can help connect conditions with their inheritance.\n\nNext step: Write the assumptions before the numbers in your next pedigree problem. See the inheritance patterns guide (https://every-gene.academy/articles/genetics-inheritance-patterns-guide/) for the full model and its limits.\n\nSources: Mendelian calculations are original worked examples. Use the NHGRI genetics glossary (https://www.genome.gov/genetics-glossary) for terminology and condition-specific references for exceptions."
    },
    {
      "type": "article",
      "title": "ABGC Exam Day: What to Expect and How to Prepare",
      "url": "https://every-gene.academy/articles/abgc-exam-day-tips/",
      "description": "Prepare for ABGC exam day with a guide to logistics, timing, scoring, and question strategy. Find links to official candidate resources and exam instructions.",
      "author": "EveryGene",
      "published": "2026-11-04",
      "updated": "2026-11-05",
      "text": "You have been studying for months. The final days and the exam session itself are about protecting your preparation, managing the clock, and applying what you know. This guide covers the current exam format, a realistic approach to timing, and strategies for different question types.\n\nOfficial logistics change. Before your appointment, read the current ABGC certification and testing information (https://www.abgc.net/Certify/Certification-Process-Exam-and-Fees) , ABGC FAQ (https://www.abgc.net/Certify/Frequently-Asked-Questions-FAQs) , and candidate guide resources (https://www.abgc.net/CERTIFY/About-the-CGC-Credential) and the appointment instructions you receive from the testing provider.\n\n### Exam Format and Provider\n\nThe ABGC examination is computer-based and is currently administered through Prometric. ABGC materials also describe remote testing options, so do not assume that traveling to a test center is the only way to sit for the examination.\n\nThe examination contains 200 questions with four hours of testing time. Of those, 170 are scored and 30 are pretest items that do not count toward your score. You will not know which items are pretest items while testing.\n\n#### Scoring\n\nABGC reports a scaled score on a 200–800 range, and the current passing scaled score is 600. A scaled score is not a raw percentage. Do not convert 600 into a percentage or treat a practice-set percentage as equivalent to a scaled score.\n\n#### Results\n\nCurrent ABGC candidate information describes an on-screen result after the post-exam evaluation, with an emailed PDF after the session. Check the current candidate guide and any cycle-specific notices for exceptions or updates.\n\n### What to Bring and What to Expect\n\nFollow the appointment instructions from Prometric and ABGC rather than a generic checklist. Identification requirements, permitted items, storage arrangements, and break rules can vary by site and by remote-testing setup.\n\nGeneral points:\n\n- Bring the identification required by your appointment instructions, and make sure the name matches your registration.\n\n- Do not bring study materials into the testing room.\n\n- Ask the test center about storage, breaks, and access to personal items before exam day.\n\n- If you are testing remotely, review the equipment, room, and proctor requirements in advance. Remote-proctoring rules are specific, and a break may not stop the clock in the way you expect.\n\nThe testing environment is usually a monitored room with other candidates taking different examinations. If you have a question about noise, breaks, or accommodations, contact the provider or ABGC before your appointment.\n\n### Time Management: 200 Questions in Four Hours\n\nWith 200 questions and four hours, the average is about 72 seconds per question. That is a planning average, not a target for every item. Some questions will take longer; others will take much less.\n\nA practical approach:\n\n- Read the task before the details. For long vignettes, read the question stem first so you know which details matter.\n\n- Answer and move on when you know it. Do not second-guess a confident answer to buy time you do not need.\n\n- Mark uncertain questions if the interface allows it. Make your best answer, flag the item, and return if time remains.\n\n- Check your pace periodically. Compare the number of questions completed with the time remaining rather than watching the clock after every item.\n\n- Answer every question. There is no penalty for a wrong answer, so a blank response cannot help you.\n\nIf you are falling behind, prioritize the questions you can answer efficiently and return to the longest vignettes only if time allows.\n\n### Question Strategy\n\n#### Read the qualifier\n\nWords such as \"most likely,\" \"best,\" \"least,\" \"first,\" and \"except\" change the task. A question asking for the best next step is not asking for every correct statement about the condition.\n\n#### Use the vignette's evidence\n\nFor case-based questions, identify the finding that separates the leading options. A detail such as age at onset, inheritance pattern, test result, or a specific examination finding is usually there for a reason. Avoid importing facts the vignette does not give you.\n\n#### Process of elimination\n\nEliminate options that are clearly out of scope or that answer a different question. With four options, removing two improves your odds, but the goal is to understand why the remaining options differ.\n\n#### Pedigree questions\n\nWork systematically:\n\n- List affected people and their sex.\n\n- Describe the transmission pattern, but treat it as a clue rather than proof.\n\n- Check for father-to-son transmission. Both a father and son being affected does not by itself prove that the son inherited the same causal allele from his father. Confirmed father-to-son transmission of the same causal X-linked allele would exclude X-linked inheritance for that allele.\n\n- Consider penetrance, age at onset, consanguinity, and de novo variants.\n\n- Calculate the probability the question actually asks for — transmission, carrier status, or clinical disease.\n\n#### Counseling questions\n\nIdentify the client's concern and the decision being asked. A technically accurate statement can still be a poor first response if it ignores what the person just said. Review the counseling ethics practice guide (https://every-gene.academy/guides/genetic-counseling-ethics-practice/) for worked examples.\n\n### The Final Days\n\nThere is no single correct taper. Prioritize sleep, familiar material, and a manageable review. If a small, important gap is bothering you, address it without sacrificing rest. The exact number of full-length sets and the total workload should depend on your preparation and how you feel.\n\n#### Two weeks out\n\n- Complete any remaining full-length practice you have planned and review it thoroughly.\n\n- Use your results to choose two or three areas for focused review.\n\n- Practice with the timing you expect to use on exam day.\n\n#### Two days out\n\n- Keep review light: key summaries, flashcards, or a short set of questions.\n\n- Confirm your appointment time, location or remote setup, and identification requirements.\n\n- Protect your sleep schedule.\n\n#### The night before\n\n- Set more than one alarm and confirm your route or remote-testing setup.\n\n- Put your identification and appointment information where you will find them.\n\n- Eat a normal meal and go to bed at a reasonable time. Last-minute cramming is unlikely to improve retention enough to justify the cost to your sleep.\n\n#### Exam morning\n\n- Eat breakfast with protein and complex carbohydrates.\n\n- Leave extra time for check-in and settling in.\n\n- Arrive early enough to complete the check-in process without rushing.\n\n### After the Exam\n\nIf you pass, update your credentials and notify your employer as appropriate. If you do not pass, give yourself time to process before planning the next attempt. Use your score report and your practice history to identify which areas need the most work, then build a targeted plan.\n\nPassing ABGC is one part of professional preparation; certification and licensure requirements are separate and vary by jurisdiction. See the career guide (https://every-gene.academy/articles/genetic-counseling-career-guide/) for that distinction.\n\n### One Final Thought\n\nExam preparation and exam performance are related but separate skills. You have built the knowledge base. On exam day, protect your pace, read the task carefully, and do not let one difficult question change how you approach the next one.\n\nLast reviewed: November 2026. Sources: current ABGC certification, FAQ, and candidate resources; Prometric appointment instructions. Verify cycle-specific logistics with ABGC before your examination."
    },
    {
      "type": "article",
      "title": "Genetic Counseling Careers: Roles, Training, and Certification",
      "url": "https://every-gene.academy/articles/genetic-counseling-career-guide/",
      "description": "Explore genetic counseling careers, training, certification, and licensure. Review salary sources and learn how board preparation fits your career path.",
      "author": "EveryGene",
      "published": "2026-11-04",
      "updated": "2026-11-05",
      "text": "Genetic counseling combines genetics knowledge with communication, counseling, and clinical collaboration. It is a career exploration topic rather than board-prep content, but understanding the training and credential pathway helps applicants and students place board preparation in context.\n\nScope of practice, test ordering, and management authority vary by jurisdiction, employment setting, credentials, and team arrangements. This guide describes common roles; it is not a legal or licensure determination for any particular position.\n\n### What Genetic Counselors Do\n\nGenetic counselors help individuals and families understand genetic conditions and the role genetics plays in their health. In a typical role, a genetic counselor may:\n\n- Assess personal and family history for genetic risk factors\n\n- Educate clients about testing options and coordinate testing\n\n- Interpret results in the context of the clinical question and family history\n\n- Counsel about recurrence risk, inheritance, and reproductive or management options\n\n- Communicate with physicians and specialists so genetic findings are integrated into care\n\n- Support clients emotionally as they navigate uncertainty, grief, or significant decisions\n\nThe role requires scientific depth and communication skill. It is not a substitute for independent medical diagnosis or management; those responsibilities depend on the setting, the clinician's licensure, and the care team.\n\n### Specializations\n\nGenetic counselors work in many areas, including:\n\n- Prenatal genetics — chromosomal conditions, structural anomalies, carrier screening, and reproductive decision-making\n\n- Cancer genetics — hereditary cancer syndromes, risk assessment, surveillance, and prevention discussions\n\n- Pediatric and clinical genetics — diagnosis and management of children with genetic conditions or developmental differences\n\n- Cardiovascular genetics — inherited arrhythmias, cardiomyopathies, and connective tissue disorders\n\n- Neurogenetics — hereditary neurological conditions\n\n- Laboratory genetics — variant interpretation, quality assurance, and test development\n\n- Pharmacogenomics — medication selection and dosing based on genetic information\n\nTitles and responsibilities differ across employers. Some positions are primarily clinical; others are laboratory, research, industry, or telegenetics roles.\n\n### Training Pathway\n\n#### Step 1: Undergraduate preparation\n\nMost applicants complete a bachelor's degree in biology, genetics, biochemistry, psychology, or a related field. Genetics coursework is important, but programs consider the whole application.\n\n#### Step 2: Accredited master's program\n\nGenetic counseling training is at the master's level. Programs accredited by the Accreditation Council for Genetic Counseling (ACGC) (https://www.gceducation.org/) combine coursework with supervised clinical training and typically take about two to two and a half years.\n\nAdmission is competitive, and requirements vary by program. There is no universal GPA cutoff such as 3.5. Programs use holistic review and may weigh coursework, experience, personal statements, and interviews differently. Check the accredited program list (https://www.gceducation.org/find-a-program/) and each program's current requirements rather than treating a sample applicant profile as an eligibility rule.\n\n#### Step 3: Certification\n\nGraduates may sit for the ABGC certification examination and, after passing, use the Certified Genetic Counselor (CGC) credential. Eligibility requirements and application procedures are set by ABGC (https://www.abgc.net/Certify/Certification-Process-Exam-and-Fees) ; use its current professional requirements information.\n\nThe examination is computer-based and currently contains 200 questions with four hours of testing time. Of those, 170 are scored and 30 are pretest items. The current content outline has five domains covering clinical and developmental information; risk and human genetics; testing and reproductive risk; counseling and education; and professional, legal, resource, and reimbursement topics.\n\n#### Certification is not the same as licensure\n\nPassing ABGC is not a universal, one-step authorization to practice independently everywhere. Licensure or other regulation is separate and varies by state or province, and employer credentialing may add requirements. Check the rules for the jurisdiction where you intend to practice in addition to ABGC certification.\n\n### Salary Information\n\nSalary figures describe particular populations and time periods. The figures below offer context for exploring career options.\n\nThe U.S. Bureau of Labor Statistics reports a median annual wage of $100,040 for genetic counselors in May 2025 ( BLS Occupational Outlook Handbook (https://www.bls.gov/ooh/healthcare/genetic-counselors.htm) ). A median is the midpoint of the reported distribution, not an entry-level guarantee or a starting offer.\n\nThe National Society of Genetic Counselors publishes its Professional Status Survey (https://www.nsgc.org/Research-and-Publications/Professional-Status-Survey) . Its 2026 executive summary (https://www.nsgc.org/Portals/0/Docs/NSGC%202026%20Professional%20Status%20Survey%20Executive%20Summary_Final.pdf) reports $104,000 as the median for the full-time, all-positions salary group, a figure that includes U.S. and Canadian respondents with currency conversion. That is a different statistic from the BLS median, and it should not be confused with the reported mean of $114,731.\n\nSalary varies by role, setting, experience, geography, and whether the position is full-time. Laboratory and industry roles may differ from clinical positions, but no single range applies to every employer.\n\n### Job Outlook\n\nBLS projects 10% growth for genetic counselors over 2025–2035. That is a long-term national projection, not a guarantee of immediate hiring or uniformly strong demand in every specialty or region.\n\nThe NSGC's current summary also describes a longer job-search timeline for new graduates than in earlier surveys. A growing field can still be competitive at entry, so build clinical exposure, networking, and application materials deliberately.\n\n### How Board Preparation Fits In\n\nFor many graduates, the ABGC examination is the final step before using the CGC credential. Effective preparation combines content review with application practice: answering unfamiliar questions, reviewing explanations, and returning to concepts later.\n\nEveryGene Academy supports genetic counseling learners preparing for ABGC and medical genetics learners preparing for ABMGG. Academy includes shared core genetics plus ABGC-focused and ABMGG-focused content.\n\nIf you are exploring the career, start with the ACGC accredited program directory (https://www.gceducation.org/find-a-program/) . Preparing for ABGC? Start with the study guide (https://every-gene.academy/guides/abgc-board-exam-study-guide/) , try the free ABGC-style sample questions (https://every-gene.academy/practice/abgc-questions/) or review the Academy plans (https://every-gene.academy/pricing/) .\n\nLast reviewed: November 2026. Sources: BLS Occupational Outlook Handbook (May 2025 wage data; 2025–2035 projections); NSGC Professional Status Survey 2026 executive summary; ACGC accredited program information; ABGC certification and professional requirements resources. Verify current requirements with the relevant body before applying."
    },
    {
      "type": "guide",
      "title": "ABGC Genetic Counseling Board Exam Study Guide",
      "url": "https://every-gene.academy/guides/abgc-board-exam-study-guide/",
      "description": "Build an ABGC study plan with the official content outline, focused practice questions, genetics flashcards, and free math and pedigree workbooks.",
      "author": "EveryGene",
      "updated": "2026-11-05",
      "text": "Start with the current ABGC content outline resources (https://www.abgc.net/Diplomate-Resources/Program-Director-Resources) ( current outline PDF (https://www.abgc.net/Portals/0/2023%20CGC%20Exam%20Content%20Outline.pdf) ), candidate guide resources (https://www.abgc.net/CERTIFY/About-the-CGC-Credential) , and official practice examination (https://www.abgc.net/Exam-Resources/Practice-Exam) . Identify your weakest areas, and build a repeatable cycle of practice, explanation review, and later retrieval. A useful study plan gives you a way to decide what to do next when your question results reveal a gap.\n\n### Use the official outline as your map\n\nRead the ABGC examination resources (https://www.abgc.net/Diplomate-Resources/Program-Director-Resources) before choosing a resource stack. Turn the content areas into a checklist and mark your current confidence. Familiarity from a recent rotation can be helpful, but it does not establish that you can answer an unfamiliar question independently.\n\nDo a manageable mixed practice set early in preparation. Record both incorrect answers and correct answers that involved guessing. Use those results to choose your next focused session; do not wait until you have reread every course note to begin practicing.\n\n### Match the resource to the task\n\nUse EveryGene Academy (https://app.every-gene.academy/) for board-style application and explanation review. Use the 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) for condition-focused retrieval. When probability or inheritance is the problem, work through the free Math Workbook (https://www.every-gene.com/math-workbook) or Pedigree Workbook (https://www.every-gene.com/pedigree-workbook) with your reasoning written out.\n\nFor counseling questions, identify the client's concern and the decision being asked. A technically accurate statement can still be a poor first response if it ignores the concern in the vignette. Practice counseling reasoning separately from syndrome recognition.\n\n### Make review part of the session\n\nAfter each set, explain why your selected answer was right or wrong. Write one short correction that you could use on a different question. For example, replace \"review recessive inheritance\" with \"an unaffected sibling of an affected child has a 2/3 carrier probability under the standard fully penetrant carrier-parent model.\" Return to that concept later without looking at the answer.\n\nIf the correction is a calculation, work a fresh version in the free Math Workbook (https://www.every-gene.com/math-workbook) . If it is a condition-recognition gap, turn it into a retrieval prompt with the 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) before returning to Academy.\n\nIntroduce timed mixed sessions as your content base becomes more stable. In the final phase, use the current official practice resources to familiarize yourself with the board's own presentation and instructions.\n\n### Keep the plan realistic\n\nChoose a core question resource, a concise review resource, and a place to track mistakes. Add another resource only when it solves a specific gap. There is no EveryGene score threshold validated to predict passing the ABGC examination.\n\nNext step: Try free ABGC-style practice questions (https://every-gene.academy/practice/abgc-questions/) , then use the study schedule guide (https://every-gene.academy/guides/genetics-board-study-schedule/) to plan your week.\n\nOfficial resources: ABGC content outline resources (https://www.abgc.net/Diplomate-Resources/Program-Director-Resources) ( current outline PDF (https://www.abgc.net/Portals/0/2023%20CGC%20Exam%20Content%20Outline.pdf) ), candidate guide resources (https://www.abgc.net/CERTIFY/About-the-CGC-Credential) , and official practice examination (https://www.abgc.net/Exam-Resources/Practice-Exam) . Learning methods: Roediger and Karpicke 2006, PMID 16507066 (https://pubmed.ncbi.nlm.nih.gov/16507066/) ; Cepeda et al. 2008, PMID 19076480 (https://pubmed.ncbi.nlm.nih.gov/19076480/) . The workflow is an EveryGene study recommendation, not an exam-outcome finding.\n\nBefore scheduling sessions, fill in the ABGC planning worksheet and weekly calendar (https://every-gene.academy/articles/how-to-prepare-for-abgc-board-exam/#fill-in-your-planning-worksheet) . Use this guide for the practice, explanation-review, and retrieval cycle inside each block."
    },
    {
      "type": "guide",
      "title": "Free Genetics Study Resources and Board Prep PDFs",
      "url": "https://every-gene.academy/guides/free-genetics-study-resources/",
      "description": "Find free genetics PDFs for pedigrees, probability, Bayesian analysis, Hardy-Weinberg practice, and pediatric board-style questions.",
      "author": "EveryGene",
      "updated": "2026-11-05",
      "text": "Choose a free resource based on the task you want to practice. A worksheet helps when you need to show a calculation; a case question helps when you need to interpret a presentation. You do not need to purchase a paid EveryGene resource to begin with the free materials listed here.\n\n### Free genetics PDF workbooks\n\n#### Pedigree Workbook\n\nFor family-history reasoning: practice drawing the evidence, proposing an inheritance pattern, and writing the assumptions before the calculation.\n\nGet the free workbook → (https://www.every-gene.com/pedigree-workbook)\n\n#### Genetics Math Workbook\n\n36 questions for probability and risk calculations: work Bayesian, Hardy-Weinberg, and carrier-risk problems with the steps written out.\n\nGet the free workbook → (https://www.every-gene.com/math-workbook)\n\n#### Pediatric Genetics Workbook\n\n20 questions for pediatric case review: apply genetics concepts to board-style questions with explanations. A focused resource, not a complete pediatric board course.\n\nGet the free workbook → (https://www.every-gene.com/pediatric-workbook)\n\nEach button opens the existing workbook page, where you can complete the free fulfillment steps to receive the PDF.\n\n### Pedigree interpretation and inheritance\n\nThe free EveryGene Pedigree Workbook (https://www.every-gene.com/pedigree-workbook) provides practice with pedigree interpretation, inheritance patterns, and risk reasoning. Use it when a family-history question feels understandable while reading the explanation but difficult to solve on your own.\n\nWrite down both your proposed inheritance pattern and the evidence for it. Check whether an alternative pattern could also fit the available family information. Review the current product page for available language versions and download options.\n\n### Genetics math and probability\n\nThe free Genetics Math Workbook (https://www.every-gene.com/math-workbook) provides written practice with probability, Bayesian analysis, Hardy-Weinberg equilibrium, and related concepts. Keep the calculations visible so you can find the point where your reasoning changed. Use it alongside the probability guide (https://every-gene.academy/guides/genetics-probability-bayesian-risk/) and Hardy-Weinberg examples (https://every-gene.academy/guides/hardy-weinberg-practice/) .\n\n### Pediatric genetics questions\n\nThe free Pediatric Genetics Workbook (https://www.every-gene.com/pediatric-workbook) offers board-style questions with explanations. It gives pediatric learners an introduction to applying genetics concepts in case-based review. It is a focused genetics resource, not a complete pediatric board preparation course.\n\n### Public questions and official resources\n\nTry the public ABGC-style examples (https://every-gene.academy/practice/abgc-questions/) or medical genetics examples (https://every-gene.academy/practice/medical-genetics-questions/) without entering the paid question bank. Use the official ABGC content resources (https://www.abgc.net/Diplomate-Resources/Program-Director-Resources) and ABMGG blueprints (https://www.abmgg.org/initial-certification/content-outlines-and-blueprints/) to define your examination scope. GeneReviews (https://www.ncbi.nlm.nih.gov/books/NBK1116/) can support condition-specific reference review; it is not itself an exam question bank.\n\n### Pair practice with original genetics flashcards\n\nFor broader application practice, explore EveryGene Academy (https://app.every-gene.academy/) . For condition-focused ABGC and ABMGG review, explore the original 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) . The free PDFs remain useful on their own or alongside Academy.\n\nFree Pedigree Workbook → (https://www.every-gene.com/pedigree-workbook)\nFree Math Workbook → (https://www.every-gene.com/math-workbook)\nFree Pediatric Workbook → (https://www.every-gene.com/pediatric-workbook)\n\nExplore the original genetics flashcards (https://www.every-gene.com/genetics-flashcard-deck)\n\nABGC outline: official resource page (https://www.abgc.net/Diplomate-Resources/Program-Director-Resources) and its currently linked content outline PDF (https://www.abgc.net/Portals/0/2023%20CGC%20Exam%20Content%20Outline.pdf) ."
    },
    {
      "type": "guide",
      "title": "Genetic Counseling Ethics Practice Questions",
      "url": "https://every-gene.academy/guides/genetic-counseling-ethics-practice/",
      "description": "Work through client-centered genetic counseling examples involving uncertainty, testing decisions, and the reasoning behind an appropriate response.",
      "author": "EveryGene",
      "updated": "2026-11-05",
      "text": "Identify the client's concern and the task in the question before choosing a response. A factually correct explanation may be useful later in the visit while failing to address what the person is asking now.\n\n### Read for the immediate issue\n\nIs the vignette about understanding, uncertainty, distress, family communication, consent, or a decision? Note any safety issue or other detail that changes the priority. Then ask what information is still missing before you can help the client make an informed choice.\n\n### Practice case: A client is unsure about testing\n\nDuring counseling about optional genetic testing, a client says, “I understand the possible results, but I do not know whether I want to know.” No immediate safety issue is described. Which response best addresses the concern first?\n\n- “Let us review the testing process and possible results once more.”\n\n- “What would knowing or not knowing mean for you right now?”\n\n- “Would you like to schedule a blood draw and decide at that appointment?”\n\n- “I suggest proceeding because the result could help you plan.”\n\nAnswer: B. The client expresses uncertainty about the personal meaning of testing, not a stated lack of technical information. Exploring that meaning supports an informed choice. A may help if understanding is unclear; C moves to logistics; D recommends a direction before exploring the client's priorities. None is an automatic rule for every counseling encounter.\n\nNSGC Code of Ethics (https://www.nsgc.org/About/Code-of-Ethics-Conflict-of-Interest/Code-of-Ethics)\n\n### Practice case: a result does not resolve the question\n\nA client receives an uncertain genetic finding and asks whether it proves the suspected diagnosis. A useful response explains the uncertainty in plain language, checks understanding, and describes what additional evidence or clinical follow-up may help. It should not turn uncertainty into either a confirmed diagnosis or a dismissive \"nothing is wrong.\"\n\n### Explain why the alternative was tempting\n\nWhen reviewing a question, identify whether the competing option offered correct information at the wrong time, assumed a preference, gave false reassurance, or exceeded the evidence. Use the case details rather than memorizing \"always empathize first\" as an exception-free test rule.\n\nPractice with EveryGene Academy (https://app.every-gene.academy/) and the public GC examples (https://every-gene.academy/practice/abgc-questions/) . For the technical concepts behind the counseling scenario, the free Pedigree Workbook (https://www.every-gene.com/pedigree-workbook) , Math Workbook (https://www.every-gene.com/math-workbook) , and 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) offer complementary review.\n\nSources: NSGC Code of Ethics (https://www.nsgc.org/About/Code-of-Ethics-Conflict-of-Interest/Code-of-Ethics) ; ACMG and AMP variant interpretation guidance (https://pubmed.ncbi.nlm.nih.gov/25741868/) . Examples are original teaching scenarios, not a universal script for clinical counseling. This page is especially useful for genetic counseling preparation; the communication principles also apply in broader clinical settings."
    },
    {
      "type": "guide",
      "title": "Choosing Genetic Tests by the Suspected Mechanism",
      "url": "https://every-gene.academy/guides/genetic-test-selection/",
      "description": "Compare what karyotypes, microarrays, sequencing, and methylation studies evaluate, then practice matching the assay to the suspected mechanism.",
      "author": "EveryGene",
      "updated": "2026-11-05",
      "text": "Match the suspected disease mechanism to what the assay can evaluate. The broadest-sounding test is not automatically the most informative choice, and a negative result does not exclude mechanisms the assay did not assess.\n\n### Compare the question each method can answer\n\nMethod |\nCore question |\nImportant limit |\n\nKaryotype |\nIs there a visible chromosome number or structural change? |\nResolution is limited for small changes |\n\nChromosomal microarray |\nIs there a detectable dosage change across the genome? |\nBalanced rearrangements generally are not detected |\n\nTargeted or panel sequencing |\nIs there a relevant sequence variant in the assessed genes? |\nCoverage and included variant classes vary |\n\nExome sequencing |\nIs there a relevant sequence variant in the protein-coding regions assessed? |\nAssessed regions and variant classes vary; noncoding and some structural variants may be missed |\n\nGenome sequencing |\nIs there an explanation within a broader analysis, including selected noncoding regions? |\nBroader coverage does not guarantee detection of every mechanism or interpretable variant |\n\nMethylation analysis |\nIs there an abnormal methylation pattern at the assessed locus? |\nIt does not necessarily identify the underlying cause by itself |\n\nConfirm the laboratory's actual methods. Some sequencing assays also evaluate copy-number or other variant classes; others do not. SNP-based arrays can provide information beyond dosage, but that does not make them a universal test for imprinting disorders.\n\n### Practice case: an unresolved imprinting question\n\nA sequencing report is negative, but a child's findings continue to suggest an imprinting disorder. The laboratory confirms that methylation was not assessed. The reasoning task is to identify the mechanism still unevaluated, rather than assuming the negative result settles the diagnosis.\n\nFor suspected Prader-Willi syndrome, the current GeneReviews chapter describes first-tier evaluation with DNA methylation analysis and an oligo-SNP array. This condition-specific approach illustrates why test selection should follow the suspected mechanism and current reference.\n\n### Practice case: broad developmental findings\n\nA child has developmental delay and congenital anomalies without a clear single-gene diagnosis. The ACMG guideline supports considering exome or genome sequencing as a first- or second-tier test in its defined pediatric CA/DD/ID population. This does not mean every developmental presentation needs an identical testing sequence; phenotype, prior studies, and assay capabilities still matter.\n\nUse EveryGene Academy (https://app.every-gene.academy/) for application, 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) for condition context, and the free pedigree workbook (https://www.every-gene.com/pedigree-workbook) for family-risk reasoning.\n\nSources: NHGRI genetics glossary (https://www.genome.gov/genetics-glossary) ; MedlinePlus on genetic testing (https://medlineplus.gov/genetics/understanding/testing/) ; ACMG 2021 chromosomal microarray technical standard (https://www.gimjournal.org/article/S1098-3600%2821%2905128-5/fulltext) ; ACMG pediatric exome/genome sequencing guideline (https://www.nature.com/articles/s41436-021-01242-6) ; Prader-Willi syndrome GeneReviews (https://www.ncbi.nlm.nih.gov/books/NBK1330/) . Confirm the laboratory's actual methods for any real case."
    },
    {
      "type": "guide",
      "title": "Hardy-Weinberg Practice Problems Explained",
      "url": "https://every-gene.academy/guides/hardy-weinberg-practice/",
      "description": "Work from recessive disease frequency to allele and carrier frequency, recognize approximation limits, and practice with a free genetics math PDF.",
      "author": "EveryGene",
      "updated": "2026-11-05",
      "text": "Hardy-Weinberg questions ask you to connect allele frequencies with genotype frequencies under a population model. First identify which quantity the question gives you. An affected-person frequency and a carrier frequency require different starting steps.\n\n### Know what each term represents\n\nFor a simplified two-allele autosomal locus, p and q are allele frequencies and p + q = 1. The expected genotype frequencies are p², 2pq, and q². Under a fully penetrant recessive disease model, q² represents the affected genotype frequency and 2pq represents heterozygous carriers.\n\n### Example 1: from disease frequency to carriers\n\nAssume an autosomal recessive condition has an affected frequency of 1 in 10,000 in a population satisfying the model.\n\n- q² = 1/10,000 = 0.0001\n\n- q = 0.01, so p = 0.99\n\n- Carrier frequency = 2pq = 2 × 0.99 × 0.01 = 0.0198, or 1.98%\n\nThe exact result is about 1 in 50.5. The common rare-allele approximation 2q gives 2%, or about 1 in 50. Showing both teaches the difference: the approximation is close here, but it is not the exact calculation. Taking the disease frequency itself as the carrier frequency skips the key relationship.\n\n### Example 2: from carriers to an approximate disease frequency\n\nSuppose the carrier frequency is approximately 1 in 25 and the disease allele is rare. Using 2pq ≈ 2q gives q ≈ 1/50, then q² ≈ 1/2,500. This is an approximation. If a problem requires an exact value, solve 2q(1 − q) for q rather than replacing p with 1.\n\n### Recognize when the model is a poor fit\n\nThe simple model assumes random mating and no evolutionary forces changing allele frequencies, along with the relevant disease-model assumptions. Population structure, selection, nonrandom mating, incomplete penetrance, and more complex genetic mechanisms can make a classroom estimate unsuitable for a clinical risk calculation.\n\nDo not apply the autosomal recessive q² shortcut to every inheritance pattern. Start with the biological and population assumptions, then select the equation.\n\nUse the free Math Workbook (https://www.every-gene.com/math-workbook) for written practice and EveryGene Academy (https://app.every-gene.academy/) for case-based questions. Review Bayesian risk (https://every-gene.academy/guides/genetics-probability-bayesian-risk/) when a test result changes an individual's probability.\n\nSource context: Original worked calculations using the classical population model. NHGRI genetics glossary (https://www.genome.gov/genetics-glossary) provides related terminology. Label the model as a simplified two-allele autosomal recessive example; population structure and disease-model assumptions limit clinical application."
    },
    {
      "type": "guide",
      "title": "How to Study Genetic Syndromes for Boards",
      "url": "https://every-gene.academy/guides/how-to-study-genetic-syndromes/",
      "description": "Organize genetic conditions by mechanism, inheritance, and distinguishing findings, then connect flashcard review with board-style practice.",
      "author": "EveryGene",
      "updated": "2026-11-05",
      "text": "Use a consistent set of questions for each condition: what causes it, how it is inherited, which findings distinguish it, how it is evaluated, and which management principles matter. That structure gives you more ways to connect a condition with an unfamiliar case.\n\n### Begin with mechanism and inheritance\n\nA gene name alone does not explain a condition. Ask whether the mechanism involves a particular sequence change, altered dosage, an imprinting effect, or another process. Then ask how that mechanism changes the test or family-risk question.\n\nFor example, learning that achondroplasia involves gain-of-function FGFR3 variants links the gene to altered growth-plate signaling. For Prader-Willi syndrome, parent of origin and imprinting are central. These mechanisms require different kinds of reasoning; they are not interchangeable entries in a gene list.\n\n### Compare the nearest alternatives\n\nWhen two conditions share a feature, make a small comparison focused on the finding that would change your answer. Avoid creating a new page of notes for every overlap. Ask whether your comparison concerns age at presentation, growth, a laboratory pattern, a specific anomaly, or inheritance.\n\nDo not make every listed feature a requirement. A typical association helps you construct a differential, but real phenotypes can vary. Use references to clarify whether a finding is frequent, specific, age-dependent, or optional.\n\n### Worked comparison: two FGFR3 conditions\n\nA comparison is most useful when it changes the next decision. Achondroplasia and thanatophoric dysplasia both involve FGFR3 and altered growth-plate signaling, but they are not interchangeable:\n\nFeature |\nAchondroplasia |\nThanatophoric dysplasia |\n\nMechanism |\nGain-of-function FGFR3 variant, typically the same recurrent variant |\nDifferent gain-of-function FGFR3 variants; severe skeletal phenotype |\n\nDistinguishing findings |\nRhizomelic short stature, macrocephaly, frontal bossing, trident hand |\nSevere shortening, narrow thorax, different skeletal findings; often lethal in the perinatal period |\n\nTest implication |\nTargeted testing for the recurrent variant can be considered when the phenotype fits |\nPhenotype and imaging guide testing; the variant is not the same as the common achondroplasia variant |\n\nInheritance and recurrence |\nAutosomal dominant; most cases are de novo, but germline mosaicism affects recurrence counseling |\nAutosomal dominant; most cases are de novo. Recurrence still requires condition-specific counseling |\n\nUse this as a model: mechanism, distinguishing findings, test implications, and inheritance. Confirm details with the current achondroplasia (https://www.ncbi.nlm.nih.gov/books/NBK1152/) and thanatophoric dysplasia references before applying them to a case.\n\n### Turn the flashcard into a retrieval prompt\n\nWith the 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) , choose one task before revealing the information: name the mechanism, identify a distinguishing clue, or explain the inheritance. Answer aloud or in writing. If you cannot retrieve it, review that section and revisit it later.\n\n### Apply the knowledge in a new case\n\nFollow condition review with Academy questions (https://app.every-gene.academy/) . If a case asks for the next test, practice that decision rather than stopping at the diagnosis. For family risk, work through the free Pedigree Workbook (https://www.every-gene.com/pedigree-workbook) .\n\nNext step: Choose two conditions you often confuse and write the clue that would separate them in a vignette.\n\nClinical sources: achondroplasia GeneReviews (https://www.ncbi.nlm.nih.gov/books/NBK1152/) and Prader-Willi syndrome GeneReviews (https://www.ncbi.nlm.nih.gov/books/NBK1330/) . The study workflow is an educational recommendation.\n\nCondition reference: Thanatophoric dysplasia GeneReviews (https://www.ncbi.nlm.nih.gov/books/NBK1366/) ."
    },
    {
      "type": "guide",
      "title": "Imprinting and Uniparental Disomy Practice",
      "url": "https://every-gene.academy/guides/imprinting-uniparental-disomy-practice/",
      "description": "Work through parent-of-origin effects, uniparental disomy, and methylation reasoning with a genetics board-style practice case.",
      "author": "EveryGene",
      "updated": "2026-11-05",
      "text": "For an imprinting problem, track both which chromosome region is involved and which parent supplied the relevant contribution. A normal copy number does not establish a normal parent-of-origin pattern.\n\n### Separate copy number from parent of origin\n\nGenomic imprinting involves parent-dependent gene activity. Uniparental disomy (UPD) means both copies of a chromosome or relevant region come from one parent. These concepts are related, but neither is a synonym for a deletion.\n\n- In heterodisomy, the contribution includes two different homologues from one parent.\n\n- In isodisomy, a contribution includes two copies of the same parental homologue or segment.\n\nActual results can be more complex or mixed. Isodisomy can also matter when it makes a recessive variant homozygous, even outside a recognized imprinted region.\n\nCopy number and parent of origin are separate questions. A two-copy result does not prove one maternal and one paternal contribution.\n\n### Practice case: Can normal copy number exclude an imprinting disorder\n\nA child has Prader-Willi syndrome. Testing shows two copies of chromosome 15, both inherited from the mother. Which mechanism best explains the condition despite the normal copy number?\n\n- Loss of the usual expression of paternally expressed genes in the Prader-Willi critical region.\n\n- Loss of maternal UBE3A expression in neurons, as in Angelman syndrome.\n\n- Biallelic pathogenic sequence variants in a recessive gene in the region.\n\n- Increased chromosome 15 dosage, as in trisomy 15.\n\nAnswer: A. Maternal uniparental disomy leaves the child without the usual paternal contribution at the imprinted Prader-Willi region. Two chromosome copies do not guarantee the expected parent-specific gene expression. B describes a different imprinting disorder; C is a different disease mechanism; D would involve an extra chromosome copy rather than the two copies specified here.\n\nPrader-Willi syndrome GeneReviews (https://www.ncbi.nlm.nih.gov/books/NBK1330/)\n\n### Follow the mechanism through to testing\n\nAsk whether the assay assesses dosage, methylation, parental origin, or sequence. A methylation result may establish an abnormal imprinting pattern without fully identifying whether the cause is a deletion, uniparental disomy, or an imprinting defect. That distinction can affect recurrence counseling.\n\nAvoid memorizing one recurrence number for every person with the same syndrome label. Establishing the molecular mechanism is part of answering the family-risk question. Use the test-selection guide (https://every-gene.academy/guides/genetic-test-selection/) to compare assays.\n\nEveryGene Academy (https://app.every-gene.academy/) offers application practice, and 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) can support condition review. The free Pedigree Workbook (https://www.every-gene.com/pedigree-workbook) offers additional family-risk practice.\n\nSources: Prader-Willi syndrome GeneReviews (https://www.ncbi.nlm.nih.gov/books/NBK1330/) ; MedlinePlus on imprinting and inheritance (https://medlineplus.gov/genetics/understanding/inheritance/) . A methylation result may not identify the underlying cause."
    },
    {
      "type": "guide",
      "title": "Metabolic Genetics and Newborn Screening Practice",
      "url": "https://every-gene.academy/guides/metabolic-genetics-newborn-screening-practice/",
      "description": "Practice connecting metabolic presentations with biochemical pathways and learn why newborn screening findings require condition-specific follow-up.",
      "author": "EveryGene",
      "updated": "2026-11-05",
      "text": "Begin a metabolic vignette by identifying the clinical setting and the biochemical pattern. Then connect those findings with a pathway. Memorizing one analyte and one diagnosis can leave you unprepared when the question adds a competing explanation or asks what the result means.\n\n### Describe the pattern before naming the disorder\n\nAsk about age, feeding or fasting, illness, neurological change, and the laboratory findings actually supplied. Distinguish an abnormal screening marker from a confirmed diagnosis. A screening program's marker, cutoff, and follow-up pathway are not interchangeable with a diagnostic assay.\n\n### Practice case: Follow up after elevated phenylalanine\n\nA well-appearing newborn has an elevated phenylalanine result on newborn screening. Which next step is most appropriate?\n\n- Repeat routine screening at the next well visit before arranging further assessment.\n\n- Arrange prompt metabolic follow-up and confirmatory biochemical evaluation.\n\n- Order PAH sequencing and defer biochemical evaluation until the report returns.\n\n- Confirm an elevated plasma phenylalanine level and assign PAH deficiency without evaluating other causes.\n\nAnswer: B. A screen-positive result requires follow-up even when the newborn appears well. Confirmatory evaluation includes quantitative plasma amino acids and assessment for other causes of hyperphenylalaninemia, including pterin-related disorders, with a metabolic specialist. A delays evaluation; C substitutes a molecular-first wait for the needed biochemical assessment; D establishes an etiology prematurely. The screen identifies a finding, not one definitive molecular diagnosis.\n\nACMG elevated phenylalanine ACT sheet (https://www.ncbi.nlm.nih.gov/books/NBK55827/bin/Phenylalanine.pdf)\n\n### Applied example: hypoketotic hypoglycemia\n\nA newborn develops poor feeding, lethargy, and hypoglycemia during an illness. Ketones are inappropriately low, and the acylcarnitine profile shows a prominent C8 species. The nearest biochemical alternative is another fatty acid oxidation defect, such as very-long-chain acyl-CoA dehydrogenase deficiency, but the chain-length pattern differs. GSD I can also cause fasting hypoglycemia with relatively low ketones, often accompanied by lactic acidosis. It does not explain the characteristic C8-predominant acylcarnitine pattern in this vignette. The task is to use the pattern to choose the pathway, then confirm with the appropriate diagnostic testing.\n\n### Use a pathway to explain the findings\n\nFor a fatty acid oxidation example, ask why fasting might expose a problem in energy production and how ketone production fits the case. MCAD deficiency can involve hypoketotic hypoglycemia and prominent C8 elevation. That pattern supports a pathway-based differential; it does not remove the need for confirmation.\n\nFor other cases, work through the provided glucose, ketones, acid-base findings, ammonia, amino acids, or organic acids as relevant. Avoid forcing every metabolic disorder into the same laboratory pattern.\n\n### Review with current references\n\nUse the ACMG ACT Sheets and Algorithms for current newborn screening follow-up resources. Board preparation is not a substitute for an urgent clinical pathway when an infant is unwell.\n\nFor structured study, use EveryGene Academy (https://app.every-gene.academy/) and the 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) . Pediatric learners can begin with the free pediatric workbook (https://www.every-gene.com/pediatric-workbook) .\n\nSources: ACMG ACT sheets and algorithms (https://www.acmg.net/act-sheets-and-algorithms/) ; MCAD deficiency GeneReviews (https://www.ncbi.nlm.nih.gov/books/NBK1424/) . ACMG GSD VI and IX practice resource (2019) (https://www.nature.com/articles/s41436-018-0364-2) . These are introductory teaching examples, not a complete biochemical genetics board resource."
    },
    {
      "type": "guide",
      "title": "How to Review Missed Genetics Practice Questions",
      "url": "https://every-gene.academy/guides/review-missed-genetics-questions/",
      "description": "Turn missed genetics questions into a focused study plan by separating knowledge gaps, reasoning errors, calculation mistakes, and guesses.",
      "author": "EveryGene",
      "updated": "2026-11-05",
      "text": "A missed question becomes useful when you identify why you missed it and what would help you answer a different version. Copying the entire explanation into your notes can leave the actual learning gap unresolved.\n\n### Identify the kind of error\n\nAsk whether you lacked a fact, misunderstood the question, confused two mechanisms, made a calculation error, or guessed between the last two choices. Review correct guesses too — they may reveal the same uncertainty as an incorrect answer.\n\nFor example, suppose a problem asks for a carrier probability after a negative test. If you answered with the person's starting (prior) carrier probability, the gap is updating probability after evidence. The prior may come from population carrier frequency or from family information; it is not always a population frequency. You do not necessarily need to reread an entire chapter on the associated condition.\n\n### Write a short correction you can use again\n\nA practical error note has four parts: the topic, the reason for the mistake, the corrected rule, and a prompt for later retrieval. For that probability example, your correction might be: \"A negative result changes carrier risk according to the prior probability and the test's detection characteristics.\"\n\nPart |\nExample entry |\n\nMissed concept |\nPosterior carrier probability after a negative assay |\n\nReason for the error |\nUsed the prior as the answer instead of updating it |\n\nCorrected rule |\nCompare carrier-and-negative with noncarrier-and-negative; divide the carrier branch by the total negative branch |\n\nFresh retrieval prompt |\nRecalculate with a different prior and sensitivity, without looking at the original answer |\n\nYour retrieval prompt could be a fresh calculation with different numbers. For a syndrome question, use a prompt that distinguishes the nearest alternative. Ask which feature supports one mechanism and which feature would have changed your answer. Avoid turning every vignette into an unqualified rule such as \"this finding always means this diagnosis.\"\n\n### Choose the right follow-up resource\n\n- Use the free Math Workbook (https://www.every-gene.com/math-workbook) when you need calculation practice.\n\n- Use the Pedigree Workbook (https://www.every-gene.com/pedigree-workbook) when the problem is inheritance interpretation.\n\n- Use 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) when the gap involves condition knowledge.\n\n- Use Academy questions (https://app.every-gene.academy/) when you need another application of the concept.\n\n### Check whether the correction transfers\n\nRevisit the concept later without your notes, ideally with an unfamiliar question. Remembering the wording of an old explanation is different from applying its reasoning. If you still miss the concept, make the next review smaller and more specific.\n\nNext step: Review one recent missed question and write a correction in your own words before starting another set.\n\nSource context: Retrieval practice is supported by experimental learning research, including Roediger and Karpicke 2006, PMID 16507066 (https://pubmed.ncbi.nlm.nih.gov/16507066/) . Use the error-note format to choose your next review task."
    },
    {
      "type": "guide",
      "title": "Timed vs Untimed Genetics Practice",
      "url": "https://every-gene.academy/guides/timed-vs-untimed-genetics-practice/",
      "description": "Decide when to use untimed learning sessions and timed genetics practice, and learn how to interpret mistakes without treating QBank scores as predictions.",
      "author": "EveryGene",
      "updated": "2026-11-05",
      "text": "Use untimed practice when the main goal is understanding a concept. Use timed practice when you also want to evaluate pacing and decision-making under a limit. Both can belong in the same study plan.\n\n### Start with the question you want the session to answer\n\nIf you are learning Bayesian calculations, an untimed session gives you room to write the branches and explain each step. If you understand the calculation but consistently spend too long on it, a timed session helps you identify that pacing problem.\n\nDuring an untimed session, commit to an answer before opening the explanation. Looking up the answer while choosing changes the task into a review exercise. Review can be useful, but its percentage correct should not be interpreted as independent performance.\n\n### Introduce timing in manageable sets\n\nChoose a time limit appropriate to the official instructions for your examination and the number of questions in the set. Use a smaller mixed set first if needed. Record whether difficulty came from knowledge, reading the vignette, calculations, or repeatedly changing an answer. Review afterward without the clock.\n\nIf you rushed past a key word, identify it. If you spent too long between two options, work out which clue should have separated them. Do not assume that doing more timed questions automatically repairs a content gap.\n\n### Combine formats across the week\n\nEveryGene Academy (https://app.every-gene.academy/) supports timed and untimed practice. Use focused untimed sessions for weak concepts and mixed timed sessions to practice applying knowledge across topics. Between question sessions, retrieve condition information using 101 Must-Know Genetic Conditions flashcards (https://www.every-gene.com/genetics-flashcard-deck) . For calculations, write out examples from the free Math Workbook (https://www.every-gene.com/math-workbook) .\n\n### Keep scores in context\n\nA repeated set may reflect familiarity. An untimed open-resource set measures something different from an unfamiliar timed set. Use those differences to guide your next session. EveryGene practice scores are not validated pass predictions, and practice settings should not be described as exact replicas of a certification examination.\n\nNext step: Choose one concept-learning session and one mixed application session for the coming week.\n\nSources for examination instructions: ABGC certification and testing information (https://www.abgc.net/Certify/Certification-Process-Exam-and-Fees) and ABMGG testing process (https://www.abmgg.org/initial-certification/certification-exam/testing-process/) . Check the current cycle before assigning examination-specific timings.\n\nExam-day references: ABGC FAQ (https://www.abgc.net/Certify/Frequently-Asked-Questions-FAQs) ; ABGC candidate guide resources (https://www.abgc.net/CERTIFY/About-the-CGC-Credential) ; ABMGG exam-day instructions (https://www.abmgg.org/initial-certification/certification-exam/on-exam-day/) ."
    }
  ]
}
